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RESUMO 
Introdução: As culturas organotípicas podem ser mantidas por longos períodos de incubação 
através do uso de dois meios de cultura: o meio Optimem, com soro de cavalo, e o meio 
Neurobasal, suplementado com B27. O soro contém substâncias indefinidas e em quantidades 
desconhecidas. O meio de cultura Neurobasal, por seu turno, é totalmente definido, o que 
permite um controlo preciso do ambiente extracelular das culturas. Porém, as propriedades 
funcionais das células mantidas em meio Neurobasal não são totalmente conhecidas. Além 
disso, neste meio as fatias desenvolvem atividade epileptiforme espontânea, que se assemelha 
com a epilepsia in vivo.  
Objectivo: O objectivo deste estudo é explorar as propriedades celulares e moleculares 
correlacionadas com a epileptogénese em culturas organotípicas de hipocampo. 
Metodologia: De forma a explorar os efeitos da remoção do soro nas culturas organotípicas, 
utilizaram-se duas condições: 1) fatias mantidas num meio com soro, 2) fatias mantidas num 
meio isento de soro. Avaliou-se a integridade das fatias, a morte celular, e as propriedades 
funcionais das células. Por fim, de modo a explorar as características correlacionadas com a 
epilepsia, em fatias mantidas num meio sem soro, avaliou-se a atividade epileptiforme, a 
ativação dos astrócitos e da microglia, bem como a transcrição das subunidades dos receptores 
do GABAA e da glicina. 
Resultados: Observou-se um aumento da excitabilidade das células piramidais de CA1 nas 
fatias mantidas num meio isento de soro, bem como uma diminuição da eficiência sináptica, 
sem afectar a integridade das fatias e a morte celular. Estes efeitos, ao longo do período de 
incubação, aumentam a vulnerabilidade e incidência da atividade epileptiform espontânea, 
tendo sido observado um progressivo aumento da prevalência da atividade ictal que 
acompanhou a ativação dos astrócitos e da microglia, bem como a alteração na expressão das 
subunidades dos receptores GABAA e da glicina.  
Conclusão: As culturas organotípicas de hipocampo são um modelo útil no estudo da 
epileptogénese, uma vez que desenvolvem características semelhantes às observadas na 
epilepsia in vivo.  
 
Palavras-chave: Culturas organotípicas de hipocampo; Epileptogénese; Meio de cultura; 
Gliose; Neurotransmissão inibitória.  
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ABSTRACT 
Introduction: Organotypic hippocampal slice cultures can be maintained for long periods of time 
in vitro using an Optimem horse serum-based medium, which contains unknown quantities of 
undefined substances, or using a chemically defined Neurobasal medium supplemented with 
B27. Neurobasal B27-supplemented allows precise control of extracellular environment and 
avoids the effects of unknown growth factors. However, the functional properties of these cells 
maintained in this serum-free medium were not yet fully known. Moreover, organotypic slices 
maintained Neurobasal medium develop spontaneous epileptiform activity that resembles in vivo 
epilepsy.  
Aim: The aim of this study is to explore the cellular and molecular correlates of epileptogenesis 
in organotypic hippocampal slice cultures.  
Methodology: In order to explore the effects of serum removal, slices were maintained in two 
different conditions: 1) serum-contain growth medium, 2) serum-free growth medium. Slice 
integrity, cell death, and functional properties were evaluated. Finally, using serum-free 
organotypic slice cultures as a model of epileptogenesis, epileptiform activity, astrogliosis and 
microglia activation, as well as GABAA and glycine receptor transcripts were assessed.  
Results: Serum removal increased cells excitability and decreased the synaptic efficiency of 
CA1 hippocampal pyramidal cells, without changing the slice integrity and cell death. These 
effects, throughout incubation period, lead to increased vulnerability and incidence of 
spontaneous epileptiform activity. Ictal-like activity becomes progressively more prevalent and 
overlaps the astrocyte and microglia activation, as well as the changes in GABAAR e GlyR 
subunits expression.    
Conclusion: Organotypic hippocampal slice cultures comprise a useful model of 
epileptogenesis. They develop many features correlated with epilepsy, and can be kept as “in 
vivo-like” using a defined culture medium.   
 
Key-words: Organotypic hippocampal slice cultures; Epileptogenesis; Growth medium; Gliosis; 
Inhibitory neurotransmission.  
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1 BACKGROUND 
1.1 Epilepsy 
Epilepsy is among the most common neurological diseases affecting around 50 million 
people worldwide. There is an estimated prevalence in Europe of 4.3-7.8 per 1000 
people, and as high as 16-20 per 1000 in Africa (according with data of World Health 
Organization).  
Clinically, epilepsy is characterized by spontaneous, recurrent epileptic seizures, which 
are defined as “a transient occurrence of sign and/or symptoms due to abnormal 
excessive or synchronous neuronal activity in the brain” 1. Epilepsy is not a singular 
disease entity but a variety of disorders reflecting underlying brain dysfunction that may 
result from many different causes. It may arise due to a disruption of mechanisms that 
normally create a balance between excitation and inhibition. Such provoking factors 
include head trauma, stroke intracranial, infections, acute metabolic disruption (e.g., 
hypoglycemia, anoxia), acute drug or toxin poisoning, and neurological diseases (e.g., 
Alzheimer’s disease). The diagnosis of the epileptic syndrome is usually based upon 
several characteristics, such as symptoms, seizure types and electroencephalographic 
(EEG) patterns 2,3. 
 
Antiepileptic drugs (AEDs) are the main treatment of epilepsy. The mechanisms of 
action of the currently AEDs involve alterations in the balance between neuronal 
excitation and inhibition, with a range of mechanisms of action such as modulation of 
voltage-gated ion channels (e.g., phenytoin, carbamazepine and lamotrigine); 
enhancement of synaptic inhibitory neurotransmission (e.g., barbiturates and 
benzodiazepines); and attenuation of brain excitation (e.g., topiramate). Nevertheless, 
most of the AEDs share common mechanisms of action 4.  
Most of the patients with epilepsy respond to AEDs, but still fail to control seizures in 
approximately 30% of them. Not all forms of epilepsy have the same rate of drug-
refractoriness, being particularly frequent (70%) in adult patients diagnosed with mesial 
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temporal lobe epilepsy (MTLE). Drug-refractoriness in epilepsy is responsible for 
increased morbidity, and risk of premature mortality 5.  
When AED therapy fails to control seizures, patients with surgically remediable 
syndromes could be assessed for epilepsy surgery. However, both treatments are 
associated with adverse effects. The patients that suffer from refractory epilepsy take at 
least two AEDs, which increase the risk of cognitive complications, such as memory 
decline. Likewise, surgical therapy may produce seizure freedom, but anatomically 
disrupts neural networks necessary for cognitive processing 6. Even those patients who 
undergo surgery, are not completely free of seizure remission 7.   
Because only a minority of patients with epilepsy benefit from epilepsy surgery, there is 
a huge need of more research into the mechanisms that lead to pharmacoresistance, 
and development of novel antiepileptic drugs. 
1.1.1 Temporal Lobe Epilepsy 
Temporal lobe epilepsy (TLE) is a chronic disease that is manifested by recurrent 
unprovoked partial seizures with or without secondary generalization. MTLE, one of the 
most common types of TLE, is characterized by seizure generation from the mesial 
temporal lobe structures including the amygdala and hippocampal formation 8. 
MTLE has a typical clinical presentation. Patients often have a history of complicated 
febrile seizures or other initial precipitating injuries, such as head trauma or intracerebral 
infections, within the first four or five years of life. There is also an increased prevalence 
of a family history of epilepsy. After a 5- to 10-year latency period, seizures start to occur 
and initially respond to appropriate AED treatment. During adolescence, or later, 
seizures habitually recur, and are mostly insensitive to current AEDs 9,10.  
Histopathologically, MTLE can be subclassified as paradoxical temporal lobe epilepsy or 
hippocampal sclerosis. No lesions are observed in paradoxical temporal lobe epilepsy, 
whereas 70% of MTLE patients with hippocampal sclerosis (Ammon’s horn sclerosis) 
lesions show severe unilateral atrophy of the hippocampal formation. It is also shown, 1) 
a stereotypical pattern of cell loss in Cornus Ammonis (CA) 1 and hilus (CA4), whereas 
CA2 and dentate granule cells seem to be spared, and 2) loss of GABAergic 
interneurons in the dentate hilus. Additionally, most hippocampal sclerosis patients 
Background 
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display cell loss in other mesial temporal areas such as the entorhinal cortex (EC), 
reactive gliosis, and aberrant sprouting of dentate granule cell axons, or mossy fibers, 
which project back into the region of their proximal dendrites. Mossy fiber sprouting 
produces a monosynaptic excitatory feedback circuit that may also synapse with 
inhibitory interneurons, enhancing inhibition 8,9,11. Moreover, some studies identified 
laminar dispersion of the dentate granule cell layer in human hippocampal sclerosis. 
This may indicate a preexisting migration disturbance of the hippocampus itself which 
could predispose to the typical cell loss and neuronal reorganization, as well as synaptic 
reorganization 10,12.  
Other changes can be associated with this epileptogenic process, including alterations 
in receptors and channels on key hippocampal cell populations as well as changes in 
the relative rates of neurogenesis. For example, after seizures, the number of ectopic 
granule cells located in the hilus seems to increase dramatically 13. Nevertheless, it is 
not fully understood whether these structural abnormalities are the cause of the epileptic 
condition or the consequence of repeated seizures. In addition, the sequence of events 
leading to the development of hippocampal sclerosis and chronic epilepsy cannot be 
systematically studied because the human hippocampal tissue is often obtained at a late 
stage of chronic MTLE, and the presently used animal models display significant 
disparities comparing to the features of the human disorder 11,14. 
1.1.2 Glial Cells and Gliosis 
Glial cells are involved in maintaining, regulating, signaling and altering neuronal 
synaptic junctions. Glial cell types include: microglia, astrocytes and radial glial cells 15. 
In the mature central nervous system (CNS), microglia and astrocytes are distributed in 
large non-overlapping regions throughout the brain, in which astrocytes represent the 
major cell type while microglia cells comprise up to 20% of the total glial cells population 
16.  
Astrocytes are no longer regarded as simple supportive cells for neurons, being 
considered as the third element of a structure known as “tripartite synapse” 17,18. 
Astrocytes play a pivotal role in brain homeostasis through several cooperative 
metabolic processes that they establish with neurons, such as energy supply, 
Organotypic Hippocampal Slice Culture Model of Epileptogenesis  
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neurotransmitter recycling functions and regulation of ionic environment and interstitial 
volume 19. At the synapse, astrocytes can be stimulated by released neurotransmitters, 
which cause intracellular calcium (Ca2+) elevations and trigger gliotransmitter release 
(such as ATP, D-serine and glutamate), that in turn regulate synaptic transmission and 
plasticity 20. Furthermore, astrocytes are also interconnected with blood vessels, as 
component of the neurovascular unit that controls blood-brain barrier permeability, and 
other astrocytes by a highly ramified structure of thin processes 21. Microglia are 
considered resident immune cells of the CNS and serve as sensors and executors of 
innate immunity within the CNS. They are in a surveying state, with random filopodia-like 
protrusions. However, upon an insult or stress, astrocytes and microglia become 
reactive (activated) leading to release of pro-inflammatory mediators, following by 
release of anti-inflammatory molecules and growth factors that help to orchestrate and 
resolve the inflammatory tissue response 22.  
 
Reactive glial changes are frequently encountered in the hippocampus in association 
with MTLE in humans 23, as well as in epilepsy animal models 24,25. Moreover, recent 
evidence strongly suggests that glia-mediated inflammation plays a role in the 
pathogenesis of seizures and epilepsy 26 (Figure 1).  
During the activation process, microglia changes from a ramified structure to a 
hyperramified and finally to an amoeboid morphology. The amoeboid morphology 
facilitates the microglial cell migration through the parenchyma toward lesion sites 22. 
Furthermore, microglial cells can increase in number since they are capable of 
proliferating 27.  
Reactive astrogliosis is characterized by cellular, molecular, morphological and 
functional changes in astrocytes and can be classified in three main categories: 1) 
reversible alterations in gene expression, 2) cell hypertrophy with preservation of cellular 
domains, and tissue structure and 3) newly proliferated astrocytes, with rearrangement 
of tissue structure and deposition of dense collagenous extracellular matrix 15. When 
normal feedback mechanisms fail to limit and extinguish inflammation, this glia-mediated 
response can result in harmful consequences to the surrounding cells 15. For example, 
chemokine-activated microglia cooperate with astrocytes in releasing tumor necrosis 
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factor-α (TNF-α), and other cytokines, which in turn promotes glutamate release from 
astrocytes 23. The increased synaptic glutamate causes paroxysmal depolarization shifts 
in neurons, contributing to neuronal synchronization and cell loss 15. Moreover, 
environmental toxins and products released upon neuronal death or damage induce 
overactivation of glia cells. The overactivated astrocytes and microglia can then release 
several cytotoxic substances including nitric oxide (NO) or superoxide and the pro-
inflammatory factors interleukin-1β (IL-1β) and TNFα 22. Chronically activated 
astrocytes, can also leads to formation of a glial scar, considered to have both beneficial 
and detrimental effects 28. In this environment axon regeneration fails and remyelination 
may also be unsuccessful. However, glial scars can also protect neurons from oxidative 
stress, and restrict the spread of inflammatory cells 23.  
Another mechanism by which glial cells can contribute to epileptogenesis is through 
functional and molecular changes of astrocytes. Altered astrocytic transporters, including 
reduced expression of potassium channels and dislocation of water channels favor an 
altered water influx and impaired potassium buffering 15. Consequently, the impairment 
of the osmotic balance increases the susceptibility to seizure. In addition, 
gliotransmission impairment by reactive astrogliosis has been described. For example, 
downregulation of glutamine synthetase (GS) expression leads to rapid depletion of 
synaptic Gamma-AminoButyric Acid (GABA). On the other hand, adenosine kinase 
(ADK) deregulation may be central to epileptic synchronization, since ADK is a 
predominantly astrocytic enzyme that regulates brain extracellular adenosine levels, 
which is a powerful inhibitory substance during seizures 23.  
Together with dendritic sprouting and new synapse formation, loss of astrocytic domain 
organization may contribute to the structural bases of recurrent excitation in epilepsy. 
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Figure 1| Intersecting roles of astrocytes and microglia in epilepsy. (1) A precipitating injury such as trauma, or 
seizures causes astrocytic and microglial activation. (2) Inflammatory proteins are released by activated glia. (3) 
Activated astrocytes exhibit homeostatic functions such as increased glutamate uptake (a function also displayed by 
microglia), glutathione release to decrease oxidative stress, adenosine release to control neuronal excitability, 
regulation of fluid/ion homeostasis, and release of anti-inflammatory mediators to control innate immunity activation. 
(4) Normal inactivation of activated microglia is partly mediated by astrocytes through inhibit microglial phagocytosis 
and lower microglial production of anti-inflammatory molecules. (5) Chronic uncontrolled astrocytic and microglial 
activation is associated with excessive release of pro-inflammatory molecules, ionic imbalance, and decreased glial 
glutamate reuptake and GABA synthesis in neurons. This set of phenomena has numerous detrimental effects, 
including neuronal injury and seizures induction. (6) Chronically activated astrocytes can form a glial scar. The effects 
of such a scar can decrease axonal regeneration, protect neurons from oxidative stress, and restrict the spread of 
inflammatory cells. (7) Epileptogenesis, seizures, and neuronal injury can arise from chronic pathological glial 
activation and cause pro-inflammatory changes that maintain chronic, pathological activation of astrocytes and 
microglia (adapted from Devinsky et al., 2013 23).  
1.1.3 GABAergic Inhibitory System  
GABAergic system plays an important role in the central regulation of somatic and 
mental functions, as it serves as the main fast inhibitory neurotransmitter in the brain. It 
is a target for several AEDs, being an important mechanism for controlling excessive 
excitatory activation, as occur in epilepsy 29. 
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1.1.3.1 GABAergic synapses 
GABA is localized primarily in short-axon interneurons that synapse on cell bodies and 
proximal axons (Figure 2). GABA is formed by transamination of 𝛼-ketoglutarate to 
glutamic acid, followed by decarboxylated by glutamic acid decarboxylase (GAD). 
Synaptic release can occur via vesicular or nonvesicular processes. Vesicular GABA 
release is Ca2+-dependent and triggered by high potassium (K+) concentration. This 
process is regulated by negative feedback control through presynaptic autoreceptors 
(e.g., kainate receptors, adrenoreceptors and GABAB receptors). Nonvesicular GABA 
release is Ca2+-independent and occurs secondary to depolarization of the cell 
membrane and sodium (Na+) influx. Synaptically released GABA can either activate 
GABA receptors (GABARs), or be transported into nerve terminals and astrocytes 
through GABA transporters (GATs), GAT-1 and GAT-3, respectively. Reuptake into 
axon terminals allows immediate recycling by vesicular uptake. Astrocytes reuptake, in 
turn, leads to GABA metabolism. GABA is metabolized into succinic semialdehyde 
(SSA) by 2-oxoglutarate aminotransferase (GABA-T), and SSA is then converted to 
succinic acid, by succinic acid semialdehyde dehydrogenase, entering in the Kerbs cycle 
29–31. 
 
 
Figure 2| GABAergic axo-dendritic synapse. The synthesis of GABA from glutamic acid in nerve terminals is 
catalyzed by L-glutamate-1-carboxylase (GAD), and the degradation of GABA into succinic semialdehyde (SSA) in 
nerve terminals and glial cells is catalyzed by 2-oxoglutarate aminotransferase (GABA-T). The GABA release system 
is regulated by presynaptic autoreceptors. GABA acts on postsynaptic receptors, GABAAR and GABABR (Adapted 
from Krogsgaard-Larsen, 1980 30). 
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Postsynaptically, GABA acts on two types of GABARs: GABAARs, which mediate the 
fast, and transient inhibitory postsynaptic currents (IPSCs), and GABABRs, which 
mediate the slow inhibitory postsynaptic currents (sIPSC). GABAARs controls chloride 
(Cl-) entry into the cell, whereas GABABRs increases K+ conductance, decrease Ca2+ 
entry, and inhibits the presynaptic release of other transmitters 32.  
The effect of GABA transmission on the excitability of a network depends on the Cl- 
reversal potential of the postsynaptic cell, which is determined by two Cl- transporters 
NKCC1 (i.e., sodium, potassium, chloride cotransporter) and KCC2 (i.e., potassium 
chloride cotransporter). In particular, NKCC1 activity increases intracellular Cl-, whereas 
KCC2 decreases it. The developmental GABA switch from excitatory to inhibitory 
neurotransmitter is caused by a differential expression of these two transporters. In 
immature neurons NKCC1 is highly expressed, while in mature neurons NKCC1 
expression decreases and KCC2 expression increase. This transition is crucial for 
seizure susceptibility, since it affects the differentiation and migration of neurons 33,34. 
1.1.3.2 GABAA receptor  
GABAARs are pentameric in structure, with the five subunits arranged around a central 
Cl- selective pore, as shown in Figure 3. There are 19 subunits (𝛼1− 6, 𝛽1− 3, 𝛾1−3, 𝛿, 𝜀,𝜃,𝜋,𝜌1− 3) encoded by 19 distinct genes. Receptors containing two 𝛼 subunits in 
combination with two 𝛽 subunits and one 𝛾 subunit are the most common in the brain 35. 
The subunit composition determines both the biophysical properties of the receptor-
channel complex and its pharmacology, and so the sensitivity to modulators (e.g., 
barbiturates, benzodiazepines and neurosteroids). For instance, a typical 
benzodiazepine-sensitive GABAAR consists of two 𝛼 subunit subtypes (𝛼1, 𝛼2, 𝛼3, or 𝛼5), and two  𝛽 (𝛽2 or 𝛽3) subunits (or one each), and a 𝛾2 subunit 36.  
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Figure 3| Schematic representation of GABAAR structure. A – Extracellular N- and C- terminus, as well as the 
transmembrane domains TM1 to TM4. B – Most common assembly of GABAAR subunits: two 𝜶 subunits, two 𝜷 
subunits, and one 𝜸 subunit; two recognition sites for GABA and the benzodiazepine recognition site.  (Adapted from 
Tretter et al., 2012 37). 
 
Classically, GABAA receptors have been recognized as mediating phasic inhibition in 
postsynaptic neurons. However, GABAA receptors can also contribute to tonic inhibition 
38. Both phasic and tonic inhibitions are associated with different subunit compositions of 
GABAARs, GABA affinities, and rates of desensitization. Nonsynaptic receptors 
characteristically contain the 𝛿 subunit, rather than the 𝛾 subunit, and 𝛼4, 𝛼5, or 𝛼6 
subunits. Interestingly, these subunit receptor compositions are not potentiated by 
benzodiazepine receptor agonists 31,39.  
1.1.3.3 GABAARs function in epilepsy 
Impairment of GABAergic system in epilepsy has been already described from several 
lines of evidence from genetic epilepsies and animal models 40. Alterations could occur 
both pre- and post-synaptically. Presynaptic alterations include a decrease in GABA 
availability at synaptic cleft, a decrease in GABAergic neuron firing, or a decrease in the 
number of GABAergic nerve terminals. Postsynaptic alterations comprise a decrease in 
the number or types of GABAARs activated, or a change in the structural or physical 
properties of these postsynaptic GABAARs 35. Also, altered function of GABABRs has 
been described in epilepsy 41–43. However, this is still controversial since both GABABR 
agonists and antagonists showed anticonvulsant as well as pro-convulsant effects 44–46.   
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In TLE with hippocampal sclerosis, postsynaptic GABAARs alterations seem to occur 
from pathologic modifications during epilepsy, interfering directly with both number and 
subunit composition 47–51, as well as with its function 52. However, there are some 
limitations when considering the results due to the diversity of epilepsy models and to 
the different quantification methods used 35. There are also differences between rodent 
brain and human brain concerning the GABAA receptor subtypes distribution 47. Despite 
these differences, the studies were convergent in demonstrating a global increase in 𝛼1,𝛼2,  𝛽1-3, and 𝛾2 subunits expression, particularly in the dentate granule cell layer. 
This was accompanied by loss of pyramidal cells in the CA1 and CA3 layers as well as 
loss of certain interneurons in the hilus of the dentate gyrus (DG). This pattern of cell 
loss decreases innervation of the DG which can explain the compensatory increase in 
subunit expression 35,51,53. 
Similarly, several genetic studies in humans have revealed a range of idiopathic 
generalized epilepsy syndromes linked to mutations in the GABAAR, and studies in 
genetically modified mice have helped establishing the role played by subunit 
composition GABAARs in epilepsy 54. Together, these data suggest that changes which 
occur over the course of seizures activity may lead to changes in GABARs function and 
pharmacology, making more difficult to treat and stop the excessive excitation 35.  
1.1.4 Glycinergic Inhibitory System 
Since Aprison & Werman 55 have reported glycine as a neurotransmitter in spinal cord, it 
is now clear that glycine and glycine receptors (GlyRs) are present in several other 
areas of the CNS 56,57.  
In the hippocampus, the study of GlyRs has been largely ignored due to the apparent 
absence of glycinergic synaptic transmission. However, recent studies have revealed 
the expression of functional GlyRs in CA1 pyramidal cells and GABAergic interneurons, 
as well as granule cells and hilar interneurons in the DG 58,59.  
Moreover, glycine has been shown to have a dual role on synaptic transmission, as an 
agonist of GlyRs, and as a co-agonist of the excitatory N-methyl-D-aspartate (NMDA) 
receptors 57,60, thereby providing a potential mechanism underlying balanced regulation 
between excitation and inhibition in hippocampal networks. 
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1.1.4.1 Glycinergic synapse 
Glycine in CNS can be reached both from de novo synthesis from glucose through 
serine in nerve terminals, or from serine via the glycine cleavage system (GCS) in 
astroglial cells (Figure 4). At nerve terminals, serine is converted into glycine by the 
enzyme serine hydroxymethyltransferase (SHMT), a pyridoxal-5-phosphate-dependent 
enzyme. This enzyme presents two isoforms, one mitochondrial and the other cytosolic, 
which suggest that glycine synthesis from serine occurs in the mitochondria, whereas 
the conversation of glycine to serine is a cytosolic process 61.  
 
 
Figure 4| Glycinergic axo-dendritic synapse. Glycine is synthesized in the mitochondria of presynaptic terminals by 
the enzyme SHMT, and accumulated in synaptic vesicles. Glycine is released to the synaptic cleft on depolarization. 
Their synaptic action is terminated by transporters in presynaptic plasma membrane (GlyT2) and in the glial plasma 
membrane (GlyT1). Glycine is degraded in astrocytes mitochondria by glycine cleavage system (GCS) (adapted from 
Zafra et al., 1997 61) 
 
Glycine is packaged into synaptic vesicles by the H+-dependent vesicular inhibitory 
amino acid transporter (VIAAT or vGAT), which is also involved in the vesicular uptake 
of GABA. The ability of VIAAT to transport GABA and glycine may depend on the 
relative extravesicular concentration of the two amino acids. Glycine inhibits GABA 
uptake and vice versa 62–64. Glycine is released to the synaptic cleft in a Ca2+ -dependent 
manner. After acting on postsynaptic receptors, glycine is inactivated by a rapid 
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reuptake mechanism, which is mainly mediated via specific Na+/Cl- -dependent glycine 
transporters (GlyT). Until now two GlyT have been identified, GlyT1 and GlyT2, sharing 
about 50% of amino acid sequence homology but displaying different pharmacology 61. 
GlyT1 is widely expressed in astrocytic glial cells as well as glutamatergic neurons, and 
is thought to control extracellular glycine concentration and regulate excitatory 
neurotransmission mediated by glycine binding to NMDARs. GlyT2, in turn, is largely 
localized to the presynaptic terminals of glycinergic neurons in the brain stem and spinal 
cord, and is thought to provide the principal glycine uptake mechanism at glycinergic 
synapses 65,66. In addition, recent findings have shown that GlyT2, and not only GlyT1, is 
expressed and functionally active in brain astrocytes, although with a lower affinity for 
glycine than GlyT1 67. These data support the idea that glycine is mainly accumulated in 
astrocytes and hence these cells play an important role in the regulation of the 
extracellular levels of glycine 60,61,68. 
1.1.4.2 Glycine receptor  
GlyRs channels are pentameric assemblies of 𝛼 and 𝛽 subunits, arranged around a 
central pore, as represented in Figure 5. Each GlyR subunit comprises a large N-
terminal extracellular domain, four transmembrane segments (TM1-TM4), a long 
intracellular loop, which connects TM3 and TM4, and a short extracellular C-terminus. 
TM2 forms the channel pore permeable to Cl- ions, which contributes to inhibition of 
neuron firing. To date, four α subunits (α1-α4) and one β subunit of GlyRs have been 
identified 57. The α subunit is the obligatory subunit, which is capable of forming 
functional homomeric channels, while the β subunit modulates ligand binding upon co-
assembly with α subunit, and is responsible for the GlyR synaptic anchoring to the 
postsynaptic scaffolding protein gephyrin. GlyR-gephyrin interaction is reversible and 
highly dynamic, regulating the number of receptors at synapses 65,69.  
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Figure 5| Schematic representation of GlyR structure. A - Extracelular N- and C- terminus, as well as the 
transmembrane domains TM1 to TM4. B - GlyR structure outlining the ion pore. C – GlyR subtypes (adapted from 
Moss & Smart, 2001 70). 
 
The subunit composition and distribution of GlyRs differ in different brain areas and 
developmental stages. The expression of 𝛼1 and 𝛼3 subunits progressively increases 
during the first postnatal (P) week, whereas the expression of 𝛼2 subunit declines with 
development 56. Thus, it is assumed that in immature caudal CNS neurons, 
extrasynaptic 𝛼2 homomeric GlyRs are progressively replaced by 𝛼2𝛽 heteromeric 
GlyRs and then by 𝛼1𝛽 and 𝛼3𝛽 heterometric GlyRs 71. In the mature hippocampus the 
expression of extrasynaptic GlyR α2/α3 predominate, in contrast with a few synaptic 
GlyR α1β, which seems to provide a tonic inhibition in the hippocampus 72,73. It also 
indicates a potential role of GlyR in early brain development 65. Indeed, there is a 
temporal correlation between the developmental switch in GlyR function, from excitatory 
to inhibitory, and the changes in receptor subunit composition 72. The expression of 
KCC2, which determines the Cl- transmembrane gradient, becomes higher in the 
second postnatal week, thereby GlyR currents become hyperpolarizing 74.  
1.1.4.3 GlyRs function in epilepsy 
Regarding the function of glycinergic transmission on hippocampal excitability and 
synaptic circuits, previous work in vivo has reported that exogenous glycine application 
can depress seizure activity in an animal model of epilepsy 75, and can potentiate the 
antiepileptic action of inhibitors of GABA-T though synergistic interaction of the two 
inhibitory neuronal systems 76. Moreover, another studies recording glycine currents in 
hippocampal slices under hyperexcitable conditions, or recording epileptiform 
Organotypic Hippocampal Slice Culture Model of Epileptogenesis  
32 
discharges induced by magnesium (Mg2+) removal, have demonstrated that GlyR 
activation depresses bursting activity, even when GABAA receptor inhibition is 
compromised 77–79. Recently, it was shown that antagonists of the glycine transporter 
(GlyT1) significantly depressed the excitatory postsynaptic potential (EPSP)-spike 
induced, reflecting a decrease in the ability of the EPSP to generate a spike 60. Taken 
together, these findings are consistent with a possible role of GlyRs in the control of 
network activity in the hippocampus. Hence, it is speculated that the activation of GlyRs 
alone or in combination with GABAA receptors may provide an alternative therapeutic 
approach for the treatment of epilepsy. 
The predominantly extrasynaptic location of GlyRs in the hippocampus also predicts a 
tonic inhibitory role in hippocampal neuronal excitability 65. Regarding this issue, Eichler 
and co-workers 80 have observed, in TLE hippocampi obtained from patients with a 
severe course of disease, an up-regulation of α2 and α3 RNA-edited high-affinity GlyRs 
expression and a down-regulation of KCC2. This was related to increased glycinergic 
signaling at GABAergic synapses, providing elevated Glutamate/GABA ratios of 
synaptic input, reduced dendrite length and elevated susceptibility of hippocampal 
neurons to excitotoxicity. Moreover, the analysis of GlyRα3 splicing in human 
hippocampus showed that GlyR α3L is the predominant splice variant in the brain. 
Hippocampi obtained from patients with intractable TLE, showed an up-regulation of 
GlyRs α3K splice variant at the expense of the long splice variant GlyRs α3L 81. 
Together, these results predict a functional interaction between GlyRs and GABAergic 
transmission in the hippocampus of TLE, and also suggest a role in the regulation of 
glutamatergic transmission. It also adds a new sight into the pathophysiology of TLE in 
terms of increased glycinergic signalling at GABAergic synapses, provided that the Cl- 
equilibrium potential is high enough.  
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1.2 Animal Models of Epilepsy 
Animal models constitute essential tools to investigate fundamental neuronal 
mechanisms of epileptogenesis 82. In experimental epilepsy models, both control and 
epileptic groups are available for electrophysiological, neuropathological and molecular 
biological experiments 11.  
Several animal models have been created, involving pharmacologic (e.g., pilocarpine, 
kainate), electrical (e.g., kindling), genetic (e.g., knock-out mice), and other injurious 
(e.g., trauma, hypoxia, stroke) methods or stimuli, in order to mimic many types and 
causes of epilepsy in humans 83. The most commonly used animal models of MTLE are 
kainic acid- (a glutamate analogue), pilocarpin- (a cholinergic agonist) and kindling-
induced chronic seizures. The neuropathologic alterations overlap with the ones 
observed in human hippocampal sclerosis, although the CA1 sector cell loss is less 
dramatically affected in animals compared to humans. On the other hand, subconvulsive 
electrical kindling of the amygdala results in sustained hippocampal seizure activity, 
which usually does not produce gross histopathological alterations 8,11,84. However, 
these in vivo models present several disadvantages including: high mortality, the need 
for large number of animals, and the relative slow data collection due to the fairly long 
latent initial insult in relation to seizures onset 84,85.  
Given the complexity of epilepsy, there is increasing interest in simplified in vitro models 
of epilepsy that allow more detailed, well-controlled, research of cellular and molecular 
mechanisms of epileptogenesis while still preserving the critical network phenotypic 
features of epilepsy, particularly the development of spontaneous seizures 86.  
In vitro models can be acute 87, including slices and dissociated cells, or long-term 
preparations such as tissue culture 88. Acute brain slices maintain much of the needed 
circuitry to generate electrographic seizures. However, these preparations are only 
viable for some hours and thus are not useful for studying chronic epileptogenesis. 
Tissue cultures, conversely, can be maintained up to 1-2 months while retaining many 
aspects of the in vivo context (e.g., functional local synaptic circuitry, preservation of 
brain architecture). Therefore the effects of seizure activity including cell death, changes 
in neuronal interactions, and morphologic rearrangement of networks can be followed 
for extended periods of time 89–91.  
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1.2.1 Organotypic Hippocampal Slice Cultures (OHSC) 
Over the past two decades, organotypic hippocampal slice cultures (OHSCs) derived 
from perinatal rats have been developed, optimized and implemented for a variety of 
studies including both normal and disease models. There are currently two techniques 
used for culturing brain slices: the roller tube and the membrane interface techniques. 
The roller tube technique was pioneered by Hogue and later popularized and refined by 
Gahwiler (1981) 92. In 1991 Stoppini and co-workers 93 introduced the interface method, 
which was later modified by others 94. In the roller-tube cultures, slices flatten to a 
greater extent, typically into a quasi-monolayer, whereas slices in the interface method 
stay thicker and retain a semi-three-dimensional structure. The interface method allows 
hippocampal slices to survive for up to several months in culture and are suitable for 
electrophysiological recordings and for biochemical studies that require more tissue 92. 
To maintain cells in vitro for longer periods of time and to evaluate proliferation, 
migration and differentiation, media that contain components like nutrients and pH 
buffering substances are used. Horse Serum (HS) is the most commonly used in 
OHSCs, and includes a complex mixture of growth factors, proteins, vitamins, trace 
elements, hormones, etc. It also contains several unknown factors and batch-to-batch 
variations, which have been described as the cause of phenotypical differences among 
slices, resulting in high variability among results 95. Moreover, glial cells continue to 
proliferate, which usually required the addition of cytotoxic inhibitors 96. It demanded the 
establishment of a chemically defined medium that would provide long-term growth and 
healthy metabolic activity of OHSCs 97. Thus, the OptiMEM-based culture medium 
supplemented with 25% HS was replaced by a defined serum-free Neurobasal based 
medium with B27 supplement 98.  
Neurobasal medium B27-supplemented enables long-term culture without astrocyte 
overgrowth. However, agreement has not been established between scientists and 
manufacturers about the quality of cultures using Neurobasal medium B27-
supplemented 99. Indeed, very few studies have explored the different effects of serum 
withdrawal from OHSCs 100–102. 
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1.2.1.1 OHSC as a model of epileptogenesis 
OHSC can be prepared from postnatal rats, P0-P7 up to P30. Organotypic slices 
cultured from P6-P7 periods are ideally suited for epileptogenesis studies. At these age, 
the hippocampal cytoarchitecture is already established, whereas dentate granule cells 
are still proliferating, and pyramidal cells as well as interneurons are at postmitotic 
stages 103. Additionally, GABA and Glycine receptors act as excitatory 34. After two 
weeks of incubation period of maturation, at age of 14 days in vitro (DIV), the different 
cell types, synaptic contacts, and receptor expression resembles that seen in situ 
92,104,105. Nevertheless, the deafferentation and deeferentation that occurs during tissue 
slicing leads to reorganizational processes. These reorganizational processes include: 
mossy fiber sprouting; reorganization in area CA1 with extended interconnectivity 
between CA1 hippocampal pyramidal cells; and interconnections between CA1, 
subiculum and DG 106–108. Because some of this abnormal connectivity mimics aberrant 
connectivity in epileptic brain, OHSCs provide a model of chronically epileptic tissue. 
OHSCs allow exploring molecular and functional alterations at various stages, e.g., 
acute seizure syndrome, occurrence of neurodegeneration, and development of a 
chronic epileptic state 90,109.  
Despite the abnormal connectivity that is developed in OHSC, spontaneous epileptiform 
activity in the absence of pharmacological manipulation has rarely been described 110. 
Recently, Dyhrfjeld-Johnsen and co-workers 111 provide a detailed functional 
characterization of the spontaneous development and evolution of epileptiform activity 
within OHSC. A high incidence of spontaneous epileptiform activity was recorded by 
field-potential recordings from area CA3 during perfusion with the slices’ growth medium 
of OHSCs from 7 to 30 DIV. A higher incidence of spontaneous epileptiform activity 
developed later than 7 DIV with primarily interictal-like spikes and bursts at 14-17 DIV 
followed by ictal-like discharges after 21 DIV. Seizure frequency and rate of 
epileptogenesis in this model were higher than in vivo models, but the epileptiform 
activity presented similar characteristics, such as the latent period until onset of interictal 
spikes, progressive transition to ictal events and sensitivity to anticonvulsants 86,111. 
Later on, further studies explored the progression of epileptogenesis and ongoing 
neuronal death in this in vitro model. An initial peak of cell death modeled by dissection 
Organotypic Hippocampal Slice Culture Model of Epileptogenesis  
36 
in organotypic cultures, and a later secondary peak after 7 DIV, which coincided with the 
peak of seizure-like activity, was described 112.  
Both ictal activity and cell death were prevented by treatment with kynurenic acid 
(glutamatergic transmission blocker), phenytoin (anticonvulsant), and inhibitors of PI3K- 
Akt-mTOR pathway (important in apoptosis), while rapamycin led to reduced sprouting, 
however without inhibiting epileptogenesis 112,113.    
Taken together, these results outline that OHSC provide a straightforward model to 
study the cellular and molecular mechanisms involved in epileptogenesis. It retains 
several features of clinical epileptogenesis, including gradual onset, axonal sprouting, 
spontaneous epileptiform activity, activity-dependent cell death, response to 
anticonvulsants, and emergence of anticonvulsant resistance. 
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2 AIMS 
The focus of this study is to explore the cellular and molecular correlates of 
epileptogenesis in organotypic hippocampal slice cultures (OHSCs). 
 
In order to accomplish this main goal, the following tasks were pursued: 
 
I – Investigation of the effect of serum removal from the OHSC growth medium, 
through: 
• Evaluation of slice integrity; 
• Assessment of cell death;  
• Spontaneous activity recordings; 
• Functional properties. 
 
II – Characterization of the progression of epileptogenesis in OHSC growing in a 
serum-free medium, in terms of: 
• Epileptiform activity; 
• Astrogliosis and microglia activation; 
• GABAAR and GlyR transcripts expression. 
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3 MATERIALS AND METHODS  
3.1 Animals 
Sprague-Dawley rats used for experimental procedures were obtained from Harlan 
Interfauna Iberia (Barcelona, Spain). The procedures were performed according to the 
European Community guidelines (2010/63/EU) and Portuguese law concerning the 
protection of animals for scientific purposes. All efforts were made to minimize animal 
suffering and to use the minimum number of animals.  
3.2 Organotypic Hippocampal Slice Cultures 
In this work, OHSC were prepared from 6- to 7- days-old Sprague-Dawley rats, 
according to the interface culture method presented by Stoppini and co-workers 93. Rats 
were decapited, the brains were removed and placed in cold Gey’s balanced salt 
solution (GBSS) with 25 mM glucose, under aseptic conditions. Combined EC-
hippocampi were rapidly dissected out and sliced transversely at 350 µm using a 
McIlwain tissue chopper. Five slices were placed onto porous (0.4 𝜇m) insert 
membranes (PICM 03050, Millipore, Bedford, MA), which were transferred to six-well 
culture trays (Corning Costar, Corning, NY) (Figure 6). Each well contained 1 mL of 
culture medium composed of 50% OPTI-MEM, 25% Hanks’ balanced salt solution 
(HBSS), 25% heat-inactivated horse serum (HS), 25 mM glucose, 100 units/mL of 
penicillin and 100 µg/mL of streptomycin. Culture were maintained in an incubator with 
5% CO2 and 95% atmospheric air at 37ºC. This interface method allows oxygen to 
diffuse into the slice at a sufficiently high concentration to maintain tissue viability 93. 
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Figure 6| Preparation of OHSCs. (A) The hippocampus and part of the entorhinal cortex are first dissected from the 
brain. (B) Thin sections are cut under aseptic conditions using a tissue chopper. (C) Five slices are placed onto a 
single culture insert in a multiwell dish. (D) They are maintained in a CO2 incubator (Adapted from Heinemann et al., 
2006 90). 
 
In order to perform the first task, slices were maintained in two different conditions: 1) in 
serum-containing (SC) growth medium and 2) in serum-free (SF) growth medium. SC 
medium is the Opti-MEM based medium defined above, while SF medium is a 
Neurobasal A-based medium. For condition 1, medium was renewed twice a week up to 
14 DIV. For condition 2, slices were kept in Opti-MEM based medium until 3 days. 
Starting at 3 DIV, slices were kept in 1 mL of chemically defined serum-free medium: 
Neurobasal A, 2% B27, 1 mM L-glutamine, 100 units/mL of penicillin and 100 µg/mL of 
streptomycin, and decreasing horse-serum concentrations (as depicted in Figure 7) until 
a serum-free condition was reached at 9 DIV. 
 
 
 
 
 
 
 
 
 
 
 
A B C D 
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Figure 7| Schematic representation of the experimental procedure. A – Slices growing in a serum-based medium 
(50% Opti-MEM; 25% HBSS; 25% HS; glucose; antibiotics). The medium was changed twice a week 14 days in vitro 
(DIV). B – Slices growing in a serum-free medium (Neurobasal A; B27; L-glutamine; antibiotics). At 3 DIV the medium 
was changed to supplemented Neurobasal A in the presence of decreasing concentrations of HS (15%, 10% and 5%) 
until complete serum-free medium that was reached at 9 DIV, in order to ensure a condition of 0% HS at 14 DIV, the 
time of the functional and molecular analysis. 
3.3 Functional Analysis 
3.3.1 Extracellular Field Potentials  
Electrophysiology techniques enable the study of electrical properties of neurons by 
measuring voltage change or electric current from single ion channel proteins 
(intracellular recordings) to the electrical activity of neurons (extracellular recordings). 
The hippocampal slice is the principal preparation for studying functional properties of 
the neurons. This is due to its orderly anatomical arrangement of the neurons and the 
highly laminated pattern of inputs and outputs (Figure 8), which facilitates 
experimentation. The hippocampal slice has also proved to be a particularly useful in 
vitro preparation for analyzing epileptiform activity 114.  
 
 
0 DIV 7 DIV 14 DIV 
25% HS 25% HS 25% HS 
0 DIV 7 DIV 14 DIV 
25% HS 5% HS 15% HS 10% HS 
3 DIV 5 DIV 9 DIV 
0% HS 
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Figure 8| The hippocampal Network. CA – Cornu Ammonis; DG – Dentate Gyrus; Sb – subiculum; AC - 
associational commissural; MF - mossy fibres; SC - Schaffer collaterals; LEC - lateral entorhinal cortex; MEC - medial 
entorhinal cortex; PP - perforant path; LPP - lateral perforant path; MPP - Medial perforant path 115. 
 
The measurement of action potentials through extracellular field recordings is produced 
by a current flow from a group of neurons through the extracellular space. Usually those 
recordings take place in the dendritic regions of CA1 area, and are utilized to monitor 
synaptic transmission at Schaffer-collateral synapses. A bipolar stimulating electrode is 
placed on the stratum radiatum subfield of area CA1 (Figure 9). Stimuli delivered in this 
fashion stimulate the output axons of CA3 neurons that pass nearby, causing action 
potentials to propagate down these axons. Responses are typically recorded through an 
amplifier coupled to a computer, using a data acquisition software 116.  
 
There are three main components in the evoked potentials recorded extracellulary from 
CA1 area: the pre-synaptic volley, the field synaptic potential and the population spike.  
The pre-synaptic volley is a biphasic deflection that results from the sum of the action 
potentials of the afferent fibers stimulated. It is an indicator of the pre-synaptic action 
potential arriving at the recording site (Figure 9A, a). 
The field synaptic potential is a negative wave if recorded at the stratum radiatum 
level. It reflects the activity of field excitatory postsynaptic potentials (fEPSPs), which 
correspond to a manifestation of synaptic activation (depolarization) in the CA1 
pyramidal neurons. For measuring fEPSPs, the parameter typically measured is the 
initial slope of the EPSP waveform (Figure 9A, b). The changes in the excitatory 
synaptic activity are reflected in the initial slope, while the changes in the inhibitory are 
mostly reflected in the late phase, i.e., ascendant slope.  If there is recording from the 
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cell body layer, so called stratum pyramidale, the EPSP is an upward deflection, and if 
the cells fire action potentials, the EPSP has superimposed upon it a downward 
deflecting spike (Figure 9B), the population spike 117.  
 
 
Figure 9| Drawing of the slice preparation showing electrode placements population responses. SR – Stratum 
radiatum; SP – Stratum pyramidale; A – Population EPSP recording, (a) – Pre-synaptic volley, (b) – EPSP waveform; 
B – Population spike recording.  
              
Information about synaptic transmission can be obtained by constructing input-output 
(I/O) curves. The plots are obtained from the measurement of fEPSP slope versus 
stimulus intensity. The shape of the curve reflects the number of fibers activated at the 
different stimulus intensities and the fEPSPs that result from these activated fibers. 
Therefore, changes in the excitability or threshold of the postsynaptic neurons could be 
measured so that for a given EPSP a neuron is more likely to fire 118.  
Since field potentials reflect activity of a population of neurons, they can be used to 
monitor epileptiform activity. It is due to the capacity of some populations of neurons to 
generate high-frequency synchronous discharges underlining the development of 
epileptogenesis 119.  
3.3.1.1 Input-Output (IO) curves 
I/O curves in slices, maintained in the two different growth medium (section 3.2), were 
performed in order to evaluate serum effects on basal synaptic transmission.  
 
 
 
CA1 
CA3 
DG 
Subiculum 
Alveus 
SR 
SP 
 
 
Population spike recordings 
EPSP recordings 
 
 
 
  
Stimulating Electrode 
 
b 
  
a 
  
A 
B 
Organotypic Hippocampal Slice Culture Model of Epileptogenesis  
44 
Individual slices were cut off from the insert and transferred to the submersion recording 
chamber (1 mL capacity). Slices were continuously superfused at a constant flow (3 
mL/min) with prewarmed (34ºC ± 0.2 ºC) and oxygenated (5% CO2/95% O2) Krebs 
solution of the following composition (mM): NaCl 124, KCl 3, NaHCO3 26, Na2HPO4 
1.25, MgSO4 1, CaCl2 2, glucose 10. After 20 minutes immersed in Krebs solution to 
ensure the energetic and functional recovery of the slices, fEPSPs were recorded 
through an extracellular microelectrode (4M NaCl, 2-4MΩ resistance) placed in stratum 
radiatum of CA1 area. Stimulation (rectangular 0.1 ms pulses, once every 15 s) was 
delivered through a concentric electrode placed on the Schaffer collateral/commissural 
fibers, in stratum radiatum near CA3-CA1 border. The intensity of stimulus (60-300 𝜇A) 
was initially adjusted to obtain a large fEPSP slope, with a minimum population spike 
contamination, and recording for at least 15 minutes until obtain a stable baseline. 
Stimuli delivery was then successively increased by steps of 20 𝜇A, with a supra-
maximum stimulation amplitude of 300  𝜇A. For each stimulation condition, data from 
three consecutive average fEPSP (of a mean of eight individual fEPSP) was stored. 
The I/O curve was plotted as the relationship of fEPSP slope vs stimulus intensity, which 
provides a measure of synaptic efficiency.   
Recordings were obtained with Axoclamp 2B amplifier and digitized (Axon Instruments, 
Foster City, CA), and monitored on a personal computer with the WinLTP software 120.  
3.3.1.2 Epileptiform activity recordings 
To monitor the epileptiform activity in OHSCs, a recording system using the interface 
type chamber as previously described by Dyhrfjeld-Johnsen 111 (Figure 10), was 
established.  
Individual slices at 14 to 30 DIV were transferred to the interface recording chamber with 
a humidified gas (95% O2/5% CO2) atmosphere at 36ºC with Neurobasal serum-free 
medium (section 3.2), continuously superfused and recirculating at a rate of 2 mL/min. 
After a 20 minutes equilibration period, field-potential recordings were performed with an 
extracellular microelectrode (4M NaCl, 2-4MΩ resistance) positioned in the CA3/CA1 
pyramidal cell layer over 30-40 minutes. 
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Figure 10| Setup for extracellular recordings 
 
Continuous recordings were obtained with Axoclamp 2B amplifier and digitized (Axon 
Instruments, Foster City, CA), running on the WinLTP software. Data analysis was 
carried out by pCLAMP 10 software program (Molecular Device Corporation, CA).   
3.3.2 Patch-Clamp Recordings 
Whole-cell recordings are from single cells as opposed to a population of cells. In this 
technique, electrical events in individual neurons are detected even when they are not 
synchronized across the population. There are two configurations: current-clamp and 
voltage-clamp. The membrane potential is recorded in current-clamp configuration. 
Recording currents instead of potentials allows the properties of synapses to be studied 
without the effects of changing ionic driving forces, which result from changing potential 
121.  
3.3.2.1 Whole cell recordings 
The slices were transferred to a Carl Zeiss Axioskop 2FS upright microscope (Jena, 
Germany) equipped with infrared video microscopy and difference contrast optics. The 
recording chamber was continuously superfused by a gravitational superfusion system 
at 2-3 mL/min with pre-warmed Krebs solution.  
Patch pipettes (1.5mm outer diameter, 0.86 inner diameter, Harvard Apparatus) made 
on a pipette puller (PC-10 Puller, Narishige Group) were filled with an internal solution 
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containing (mM): K-gluconate 125; KCl 11; CaCl2 0.1; MgCl2 2; EGTA 1; HEPES 10; 
MgATP 2; NaGTP 0.3 and phosphocreatine 10, pH 7.3, adjusted with KOH (1M), 280-
290 mOsm. 
To optimize success of recording from pyramidal neurons, phase-bright cells were 
selected based on both size and pyramidal shaped soma.  
Whole-cell was recorded in a current clamp plus mode with an EPC-7 amplifier (List 
Biologic, Campbell, CA). Offset potentials were nulls directly before giga-seal formation. 
Immediately after establishing whole-cell access, the membrane potential (Vm) of the 
neurons was measured in current-clamp mode.  
Data acquisition was carried out by AxoScope 10 software program (Molecular Device 
Corporation, CA).  
3.4 Molecular Analysis  
3.4.1 Quantitative Real-Time PCR (qPCR) 
The polymerase chain reaction (PCR) is a simple method used for amplifying DNA 
sequences in vitro, developed in 1983 by Kary Mullis. The standard PCR reaction 
incorporates three basic steps. Firstly, the double-stranded DNA (dsDNA) is heat 
denatured (90-95ºC) to separate into two single strands. Secondly, the specifically 
designed primers are allowed to anneal on a predetermined DNA region by lowering the 
temperature (40-70ºC). Third, a thermostable DNA polymerase synthesizes the new 
DNA strand in the presence of four-deoxyribonucleotide thriphosphate (dNTPs) at its 
optimal temperature (72ºC). Each cycle of replication is repeated a pre-determined 
number of times, resulting in an exponential amplification of the number of target 
molecules each cycle. PCR amplification reactions are highly specific, depending on the 
correct hybridization of primer specific sequences 122. 
Reverse transcriptase PCR (RT-PCR) is a variant version of PCR used to detect RNA 
expression levels in a sample. To this end, reverse transcriptase is added together with 
a reverse primer and nucleotides to generate a cDNA from mRNA samples. The sample 
is then subjected to standard PCR procedures. Comparing with other techniques (e.g. 
Northern blotting, RNase protection assay), the RT-PCR assay is much more sensitive 
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since it detects very low abundance of mRNA, being ideal for detecting mRNA from 
small amount of tissue samples. However, it compromises the specificity of the reaction, 
increasing the likelihood of contamination and of detection of false positives 122,123. 
Therefore the monitoring of extracted RNA quality and the use of negative controls are 
important quality control factors in RT-PCR 124.  
The monitoring of extracted RNA quality comprises its purity and its integrity. The 
extracted RNA purity can be assessed by spectrophotometry based on an absorption 
ratio of 260/280 nm, where an absorbance ration between 1.9 and 2.0 indicates purified 
RNA, and a ratio of 2.1 indicates highly purified RNA. Since both DNA and RNA absorb 
at 260 nm, the absence of genomic DNA is commonly assessed by the use of a 
negative control. The most common method to assess the integrity of total RNA is to run 
an aliquot of the RNA sample on a denaturing agarose gel stained with ethidium 
bromide (EtBr). The ratio 2:1 between rRNA bands (28S:18S) is an indication that the 
RNA is completely intact. On the other hand, the internal RT-PCR controls allow to be 
sure that the absence of RT-PCR amplification product is not due to RNA degradation. 
This can be determined by RT-PCR amplification of mRNA from constitutively expressed 
“housekeeping” genes from the same sample of extracted RNA, or even within the same 
RT-PCR mix that is to be used for RT-PCR amplification. Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) is one of the most commonly used housekeeping genes, 
though others including 𝛽-actin and 𝛼-tubulin can also be used. The mRNA synthesis of 
these genes is considered to be stable and secure in various tissues, even under 
experimental treatments 122,125.  
 
Real-time PCR is the most sensitive and quantitative approach to PCR, which allows 
quantification of rare transcripts and assessment of small changes in gene expression. 
Real-time PCR consists in a continuous detection and quantification of fluorescent 
signal from one DNA fragment over a range of cycles, based on the wavelength light 
emitted by the dye associated to the DNA. The simplest detection technique uses the 
SYBR Green I fluorescence dye, which is a highly specific dsDNA binding dye that 
remains associated with DNA generated during the PCR amplification. The application 
of fluorescence techniques to real-time PCR combines the PCR amplification, product 
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detection and quantification of newly synthesized DNA, as well as specificity verification 
in the melting curve analysis. Melting curves provide an accurate identification of 
amplified products and distinguishing them from primer dimers and other small 
amplification artifacts 124. The advantages of the real-time PCR method are the 
possibility of being performed in a close-tube system and no requirements for post-PCR 
manipulation of sample, avoiding potential contaminations. Its high ramping rates, 
limited annealing and elongation time, the rapid PCR cycle in the LightCycle system 
offers stringent reaction conditions to all PCR components and leads to a primer 
sensitive and template specific PCR 126–128.  
 
RT-PCR data analysis can be either absolute or relative. The absolute quantification is 
adequate for precise determination of total RNA concentration, usually by relating the 
PCR signal to a standard curve. A relative quantification determines the changes in a 
steady-state transcription of a gene, always relative to a reference gene.  
There are several methods used in relative quantification analysis, which differ in their 
accuracy and reproducibility 129. Most of the methods utilize data from the exponential 
phase of PCR amplification and require setting threshold fluorescence to determine the 
threshold cycle (Ct) value. The target Ct is directly compared with the control Ct and is 
recorded as containing either more or less DNA. 
In the mathematical model developed by Pfaffl (2001) 130, the relative expression ratio 
(Rpfafll) of a target gene is calculated based on RT-qPCR efficiency (E) and crossing 
point (CP) deviation of a treated sample versus a control sample, and expressed in 
comparison to a reference gene. The normalization of target gene expression with an 
internal control gene is useful in order to compensate sample-to-sample and run-to-run 
variations and to ensure the experimental reliability. The PCR efficiency determination 
can be assessed by serial dilution of the prepared cDNA. As the diluted cDNA sample 
accumulates during the early exponential phase of the reaction the crossing threshold 
on Ct value is taken. From the various Ct values a log graph is prepared from which the 
PCR efficiency can be deduced 130.  
Materials and Methods 
49 
3.4.1.1 RNA preparation  
RNA was extracted from OHSCs according to the QIAGEN RNeasy Mini Kit. Firstly, the 
hippocampus proper was separated from EC using a dissecting microscope (Olympus). 
Then, the collected tissue was homogenized with QIAzol lysis reagent and with a 
TissueRuptor homogenizer, previously DEPC-treated.  RNA concentration was 
accurately determined using Nanodrop 1000 (ND-1000 Spectrophotometer, Thermo 
Scientific). The integrity of total RNA was confirmed by gel electrophoresis.  
3.4.1.2 Reverse transcription reaction 
In vitro reverse transcription (RT) was performed from 2 𝜇g of total RNA (in 20 𝜇L) and 
carried out with SuperScript II Reverse Transcriptase (EC 2.7.7.49, Invitrogen, 
Carlsband, CA, USA) in a thermoclycler (MyCycle – Bio-Rad, Hercules, CA 94547), 
according to the manufacturer’s recommendations (SuperScript First Strand Synthesis 
Systems for RT-PCR from Invitrogen). For each RNA sample a reverse transcription 
reaction was carried out in the absence of reverse transcriptase (negative control) to 
ensure that product amplification did not arise from genomic DNA.  
3.4.1.3 Quantification 
cDNA amplification was performed in a Rotor-Gene 6000 real-time rotary analyzer 
thermocycler (Corbett Life Science, Hilden, Germany) in the presence of SYBR Green 
Master Mix (Applied Biosystems, Foster City, CA, USA) and 0.2 𝜇M of each specific 
gene primer (Table 1). The PCR conditions included an initial denaturation for 2 min at 
94ºC, 50 cycles with 30 s at 94ºC, 90 s at 60ºC and 60 s at 72ºC, followed by a melting 
curve to assess the specificity of the reactions. The Ct and the melting curves were 
acquired with Rotor-Gene 6000 Software 1.7 (Corbett Life Science). PCR efficiency, 
needed for the relative quantification by comparative Pfaffl method (Section 3.4.1), was 
determined by calibration curves with 5-fold sequential dilutions of the cDNA for each 
gene. GAPDH was used as a reference internal standard. For each gene, replica 
reactions were performed and the mean Ct of the two reactions was used to calculate 
the corresponding expression level. Two types of negative controls, “no reverse 
transcription” and “no template” were run with samples. 
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Table 1| Primers used in qPCR. 
Gene Primer Sequence PCR Fragment Size (pb) 
GAPDH 
Forward: GTTTGTGATGGGTGTGAACC 
170 
Reverse: TCTTCTGAGTGGCAGTGATG 
GlyR 𝜶𝟏 Forward: ACTCTGCGATTCTACCTTTGG 300 
Reverse: ATATTCATTGTAGGCGAGACGG 
GlyR 𝜶𝟐 Forward: CAGAGTTCAGGTTCCAGGG 330 
Reverse: TCCACAAACTTCTTCTTGATAG 
GlyR 𝜶𝟑 Forward: GTGAGACACTTTCGGACATAC 353 
Reverse: GATGGGTCGAGGTCTAATGAATC 
GlyR 𝜷 Forward: CTGTTCATATCAAGCACTTTGC 223 
Reverse: GGGATGACAGGCTTGGCAG 
GABAAR 𝜶𝟏 Forward: TGTGGCAGAAGATGGGTCAC 252 
Reverse: AGAACGGTCGTCACTCCAAA 
GABAAR 𝜶𝟐 Forward: ACAACGGGAAAAAGTCAGTGG 331 
Reverse: ACCGTGTATTCACCTGTGCTT 
GABAAR 𝜶𝟑 Forward: CCAAGGGGAGTCAAGACGAC 190 
Reverse: AGTCACTGCATCTCCAAGCC 
GABAAR 𝜶𝟒 Forward: GGATTTGGGGGTCCTGTTAC 325 
Reverse: TGGGACACTCCGCACTTATG 
GABAAR 𝜶𝟓 Forward: TGCAACGTCTCCCTCTCAAC 388 
Reverse: TATTCACCTGTGCTGGTGCT 
GABAAR 𝜷𝟏 Forward: AGCTTGCATGATGGATCTCC 216 
Reverse: GGATATGCCCCTGTTGTGAAT 
GABAAR 𝜷𝟐 Forward: GATTTCGGAGGTCCCCCTGT 381 
Reverse: GCTTTCGATCTCCAACGTGC 
GABAAR 𝜷𝟑 Forward: ATGGAACAGTGCTGTACGGG 252 
Reverse: AGGCACCTGTGGCGAAGAC 
GABAAR 𝜹𝟐 Forward: ATCGCTCTACCCAGGCTTCA 395 
Reverse: TCCAGTGAGCATCCGCTTTT 
GlyR – Glycine receptor; GABAAR – Gamma-aminobutyric acid A receptor. 
3.4.2 Immunohistochemistry (IHC) 
Since the first use of an antibody for Immunohistochemistry (IHC) reported in 1941 by A. 
Coons and colleagues 131, IHC is considered an invaluable tool in the neuroscience field. 
This technique is based on the interaction process of detecting antigens (e.g., proteins) 
in tissue sections through specific antibodies (Abs). It has allowed studies of the 
structure and function of biologically relevant neuronal circuits 132. IHC is a robust, 
versatile and sensitive method. It is, however, largely empirical and requires a good 
understanding of its specific limitations 133. 
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The interaction antigen-Ab can be detected by either direct or indirect methods. The 
labels (reported molecules) are enzymes, fluorescent compounds, and metals, attached 
to the primary, or secondary Ab. The direct method is the simplest and involves a one-
step process. The Ab against the molecule of interest, called the primary Ab, is reaction 
chemically conjugated to the reporter molecule. The advantages of this method include 
shorter sample staining times, and in cases where one has multiple Ab raised in the 
same species a direct labelling may be necessary. However, it produces a weak signal, 
generally has high cost, and low flexibility. In the indirect method, the Ab specific for 
the molecule of interest is unlabelled, and a second anti-immunoglobulin (IgG), the 
secondary Ab, directed toward the constant portion of the first Ab is tagged with the 
reporter molecule. The indirect method has greater sensitivity and there is greater 
amplification of the signal. Commercially produced secondary Abs are relatively 
inexpensive, available in an array of colours, and quality controlled. The disadvantages 
of this method include the potential for cross-reactivity and the need to find primary Abs 
that are not raised in the same species or of different isotypes when performing multiple-
labeling experiments 134,135.  
3.4.2.1 Immunofluorescence microscopy   
Immunofluorescence (IF) microscopy uses Abs conjugated to fluorescent reporter 
molecules, called fluorophores. In order to observe fluorescence through the 
microscope, the sample is submitted to high intensity light and of specific wavelengths, 
generally in the region between 300 nm and 700 nm. The fluorophore absorbs light of 
specific wavelengths (excitation) and simultaneously re-emits part of this energy at 
longer wavelengths (emission), usually in the visible region of the spectrum. Multicolor 
fluorescence immunostaining enable to co-localize antigens not only in the same cell but 
also in the same cellular compartment, comparing with multicolor immunoenzyme 
staining applicable only for separately located antigens. However, fluorescence decays 
in time and although anti-quenching agents can be used, the preparations are not 
permanent. Fluorescent staining can be visualized with standard fluorescent microscopy 
as well as in confocal microscopes 127,134,136.  
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Confocal microscope focuses a spot of light onto a single point at a specific depth in the 
specimen. It requires a very bright source of pinpoint illumination that is usually supplied 
by a laser whose light has been passed through a pinhole. The fluorescence emitted 
from the illuminated material is collected and brought to an image at a suitable light 
detector. Confocal microscopy not only provides information on structures in an 
individual plane but also can collect multiple sections in the Z direction generating a Z-
stack. Computer programs can then reconstruct an optical image of the cell in 3-
dimensions. Another advantage of using confocal microscopy is that filtering is used to 
eliminate out-of-focus signals that otherwise degrades the quality of the image giving 
significant background. Brighter images are obtained with confocal microscopy in 
comparison to standard immunofluorescence 137. 
 
Critical limitations of the IHC protocol mainly involve issues of Ab penetration and 
antigen accessibility. Therefore, the outcome of an immunohistochemical reaction 
depends on the properties of the Abs used, as well as on several physic-chemical 
parameters of the tissue to be processed, mainly its fixation 133. 
Generally immunostaining is carried out on fixed and permeabilized tissues. Fixed 
tissues are prepared by agents, including paraformaldehyde and formaldehyde, which 
maintains structure and make the cell membranes permeable. Further permeabilization 
of aldehyde-fixed cells is usually accomplished with a detergent, such as Triton X-100. 
The agents that are used for fixation and permeabilization are strictly cell and antibodies 
dependent. Other agents, such as methanol can also be used as fixative. After 
permeabilization, tissue is treated with the primary Ab (mouse, rabbit, chicken, rat, 
donkey, etc.) followed by incubation with the fluorophore-conjugated secondary Ab 
directed to the host of the primary one. For multiple immunolabelling, if primary Abs are 
produced in same species, sequential dual labeling is necessary; if primary Abs derive 
from different species, both primary Abs can be added simultaneously. This avoids false 
positive staining. Controls for false negative are also required to assess problems of the 
specificity of an antibody 127,128,135. Due to some limitations of the immunohistochemistry, 
quantitative measurements derived from other methods should also be performed 133.  
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3.4.2.2 Culture sectioning 
Cultured slices (14 and 21 DIV) were fixed with 4% paraformaldehyde in phosphate 
buffer solution (4% PFA in PBS) for 1 hour at room temperature (RT). Slices were 
sequentially incubated in increasing concentrations of sucrose in PBS (1h in 10% and 
1h in 20%) at RT. Finally cultures were transferred to a 30% sucrose solution and 
maintained at 4ºC.  
Slices were cut off the membranes of the culture plate inserts, embedded in Tissue-Tek 
(Sakura Finetek Europe, Zoeterwoude, The Netherlands), and gradually frozen in the 
cryostat (Leica, Germany), where the chamber was maintained below -20ºC. Slices 
were then sectioned to a thickness of 20 𝜇m. The sections were collected on separate 
gelatinized slides, 3-4 slices per slide, and stored at -20ºC for further processing. 
3.4.2.3 Immunohistochemical staining 
One or two slices were surrounded with DAKO pen (Dako, Denmark) to protect staining 
areas from drying out. After PBS washes, slices were permeabilized with 1% Triton X-
100 (Sigma) in PBS for 10 minutes at RT. Washed two times, blocking buffer 6% Bovine 
Serum Albumin (BSA) in PBS was applied for 1 hour. Slices were incubated with dilute 
primary Abs (Table 2) in blocking solution for 48 hours at 4ºC. After washed with PBST 
(PBS with 0.1% Tween-20), slices were incubated with the fluorescent-labeled 
secondary Abs (donkey anti-rabbit Alexa Fluor 488, donkey anti-goat Alexa Fluor 488 or 
donkey anti-mouse Alexa Fluor 568, 1:400, Invitrogen) for 4-6 hours at RT. Nuclei were 
stained with Hoechst 33342 (20 mg/mL, Invitrogen) for 15 min at RT. Slices were then 
washed, mounted, and imaged with a confocal laser scanning microscope (LSM 710, 
Zeiss, Germany), using either an EC plan-NeoFluar 5x or a Plan-Apochromat 20x 
objective (Zeiss, Germany), with a frame size of 1024 x 1024 pixels. Negative controls 
were carried out in absence of primary Abs. 
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Table 2| Primary antibodies used in immunohistochemistry (IH) assays to target different cell population: 
astrocytes, microglia cells and neurons. 
Protein Supplier Host Dilution 
NeuN Grupo Taper Mouse monoclonal antibody 1:150 
GFAP Sigma Rabbit polyclonal antibody 1:750 
Iba-1 Abcam Goat polyclonal antibody 1:1000 
NeuN – Neuronal Nuclei; GFAP – Glial fibrillary acidic protein; Iba-1 – Ionized calcium binding adaptor molecule 1.  
3.4.2.4 Propidium iodide (PI) uptake assay 
In order to evaluate the hippocampal areas most affected by the cell loss propidium 
iodide (PI) uptake assays was performed. PI can only enter cells with already damaged 
membranes and bind to nucleic acids rendering the damaged cells brightly fluorescent 
138. PI imaging was carried out in cultured slices at 14 DIV. The slices were incubated 
with 2𝜇M sterile propidium iodide solution (Sigma, St. Louis, MO, USA) diluted in culture 
medium for 4 hours before imaging. The photographs of the stained slices were 
acquired with an EC Plan-NeoFluar 5x objective, on a widefield fluorescence 
microscope (Axiovert 200, Zeiss, Germany). Fluorescence was quantified using the 
software ImageJ software 1.44b (NIH).  
3.4.3 Western Blot (WB) 
Western blotting or immunoblotting is used to identify specific proteins as well as to 
quantify the protein expression from a complex mixture of proteins extracted from cells 
or tissues. It is based on protein interaction with a specific Ab and its relative molecular 
weight. Western blotting comprises three general steps: (1) separation by size, (2) 
transfer to a solid support, and (3) marking the target protein using a proper primary and 
secondary Ab to visualize 139.  
Protein extraction attempts to collect all the proteins in the cell cytosol. It requires 
mechanical intervention, such as homogenization, or sonication. This should be done in 
a cold temperature, in a buffer adequate to maintain pH, ionic strength and stability and 
in presence of protease inhibitors to prevent denaturing of the proteins. After extracting 
the protein, its concentration is measured using a spectrophotometer in order to 
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establish the mass of protein that will be loaded into each well by the relationship 
between concentration, mass, and volume.  
 
SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) is the most 
widely used method for analyzing proteins. It is quantitative and separates proteins 
according to their size. Firstly, the protein mixtures are diluted into a loading buffer, 
which contains SDS, glycerol, and bromophenol blue. Samples are heated at 95ºC for 
10 minutes in order to denature the higher order structure, while retaining sulfide 
bridges. SDS is an anionic detergent that binds to hydrophobic regions, and causes the 
protein to acquire a net negative charge, enabling the protein to move in an electric field 
applied during electrophoresis procedure.  
Most SDS-PAGE gel is prepared with two types of acrylamide gel, a narrow stacking gel 
above the primary separating gel. The stacking gel is slightly acidic (pH 6.8) and has a 
lower acrylamide concentration making it highly porous in order to concentrates the 
proteins into thin and sharply defined bands. The resolving gel is basic (pH 8.8) and has 
higher polyacrylamide content, making gel pores narrower. When a voltage is applied, 
the smaller proteins migrate easily within the pores, and hence rapidly, than larger 
proteins. This method ensures that all proteins enter the resolving gel at the same time, 
improving resolution and reproducibility 140.   
After separating the protein mixture, proteins can be transferred quantitatively to a 
membrane by electroblotting. Membranes are typically made of chemically inert 
substances such as nitrocellulose or polyvinylidene difluoride (PVDF). PVDF 
membranes are most used since they provide better mechanical support and allow the 
blot to be reprobed and stored. However, the background is higher in the PVDF 
membranes. The transferring process is carried on placing the membrane between the 
gel surface and the positive electrode in a sandwich so that proteins move from gel to 
membrane (blot). This procedure is carried out in wet conditions in which the membrane 
is immersed in transfer buffer. Wet conditions are preferred for larger proteins and are 
usually more reliable 139,140.   
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Identification of target proteins involves probing the blot with specific Abs. Protein 
detection encompass two steps: (1) membrane blocking, and (2) immunodetection and 
visualization. Membrane blocking is achieved by incubating the membrane in blocking 
solutions, such as protein-enriched solutions (e.g., BSA or nonfat dried milk) and anionic 
detergents (e.g., TBST) to prevent non-specific binding of antibody to the membrane 
itself. The appropriate blocking solution is reliant on compatibility detection labels. For 
example, BSA blocking solution is preferred with biotin and alkaline phosphatase (AP) 
antibody labels, and antiphosphoprotein antibodies, since milk contains casein, which is 
itself a phosphoprotein 139.  
After the blocking step, the immunodetection can be targeted either through direct or 
indirect Ab system, as described in IHC technique (section 3.4.2). For indirect labeling 
the membrane is incubated in the primary Ab solution and after washing, it is treated 
with a solution of a secondary Ab-enzyme conjugated. Horseradish peroxidase (HRP)-
coupled Abs are commonly used. HRP catalyzes the oxidation of luminol in the 
presence of hydrogen peroxide, and results in light emission capable of impressing an 
X-ray film. Thus, the image of the blot is visualized by simply exposing the blot to an X-
ray film. The signal intensity is proportional to the protein quantity on the blot, allowing 
relative quantification. The proteins bands are normalized to a housekeeping protein, 
such as 𝛼-tubulin, or 𝛽-actin, or GAPDH 140   
3.4.3.1 Whole tissue lysates 
Hippocampal tissue derived from 4-5 slices was placed in 200 𝜇L of lysis buffer, 
containing 50 mM Tris base pH 8, 1 mM EDTA, 150 mM NaCl and 1% NP40 (Fluka 
Biochemika, Switzerland) and supplemented with protease inhibitors (complete Mini-
EDTA free, Roche, Germany). Homogenization took place in a Potter-Elvehjem 
homogenizer with a Teflon piston. Cell suspension was left shaking for 15 min at 4 ºC 
and the insolubilized fraction was removed by centrifugation, 11000 g during 10 minutes 
at 4ºC. The supernatant was collected and protein was quantified using the BioRad DC 
Protein assay Kit.  
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3.4.3.2 Western blot quantification 
Samples (35𝜇𝑔  total protein/well) and protein size marker (Precision Plus Protein 
Standards, Bio-Rad) were run on a standard 12% SDS-PAGE and transferred to PVDF 
membranes.  
Subsequently, membranes were blocked for 1 hour with 3% BSA in TBST (20 mM Tris 
base, 137 mM NaCl and 0.1% Tween-20) and probed probed with the primary Abs 
(Table 3), diluted in 3% BSA with 0.02% NaN3, overnight at 4ºC. Finally, membranes 
were incubated with goat anti-rabbit or donkey anti-goat horseradish peroxidase (HRP)-
conjugated secondary antibodies (1:10000, Santa Cruz Biotechnology).  
Development of signal intensity was carried out using the ECL Plus Western Blotting 
Detection System (Amersham-ECL Western Blotting Detection Reagents from GE 
Healthcare, Buckinghamshire, UK) and quantifications were attained by densitometric 
scanning of the films, performed with the Image J software. GAPDH density was used 
as the loading control.  
 
Table 3| Primary antibodies used in western blot (WB). 
Protein Supplier Host Dilution 
GFAP Sigma Rabbit polyclonal antibody 1:5000 
Iba-1 Abcam Goat polyclonal antibody 1:1000 
GFAP – Glial fibrillary acidic protein; Iba-1 – Ionized calcium binding adaptor molecule 1;  
 
3.5 Statistical Analysis 
All statistical analysis was performed using GraphPad Prism software (San Diego, CA, 
USA). Comparisons between two conditions were made using Student’s t-Tests. Multiple 
comparisons were carried out using one-way analysis of variance (ANOVA) followed by 
Bonferroni’s correction post-test.  
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4 RESULTS 
4.1 Organotypic Hippocampal Slice Cultures 
The first step of this work was to evaluate the effects of serum removal from organotypic 
slice cultures, which concern to slice integrity, degree of cell death and functional 
synaptic transmission. As described in section 3.2, two growth conditions were 
developed: 1) cultures maintained in serum-containing media (SC), and 2) cultures 
progressively changed and maintained in a Neurobasal-based serum-free media (SF). 
Both slice cultures were evaluated at 14 DIV. 
4.1.1 Slice Integrity is not Affected by Serum-removal  
Cultures of longitudinal slices of combined EC-hippocampus were carried out in this 
work (Figure 11). The EC was maintained since it contributes to the generation of 
discharges resembling interictal and ictal events 111,141.  
 
Figure 11| Photograph of combined EC-hippocampal slice immediately after dissection. CA, cornu ammonis; 
DG, dentate gyrus; EC, entorhinal cortex; PC, perirhinal cortex;      
 
Evaluation of slice integrity was conducted by an immunofluorescence protocol, in which 
slices were labeled with an Ab against NeuN (a neuron specific nuclear protein) and 
Hoechst (a nuclear marker).  
The gradual removal of serum over a 6-day period starting at 3 DIV (sections 3.2), and 
the maintenance of slices in fully defined culture media (Neurobasal-A plus B27 
supplement) did not affect the lamellar organization of the hippocampus (Figure 12). 
NeuN positive staining, shown in panels A2 and B2, was observed in granular neurons 
DG 
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CA1 
EC 
PC 
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from DG and pyramidal neurons from CA areas, as well as interneurons present in the 
dendritic areas. As expected, Hoechst staining, illustrated in panels A1 and B1, was 
spread within the whole hippocampal structure and observed, not only in NeuN positive 
nucleus (purple color in panels A3 and B3), but also in other non-neuronal cells (e.g. 
glial cells). Nevertheless, slices derived from SF condition were more difficult to cut in 
the cryostat. This is presumably caused by larger decrease in cell density of cultures 
grown under Neurobasal SF conditions, compared with cultures maintained in SC 
medium, as previously described 102. 
 
Figure 12| Immunofluorescent characterization of organotypic hippocampal slices obtained from 14 days in 
vitro (DIV) grown in two different conditions. A) Slice grown in serum-containing medium; B) Slice grown in serum-
free medium. The first two images of each panel represent each labeling alone: blue for nuclear staining with Hoechst 
(A1 and B1) and red for NeuN stained neurons (A2 and B2). The merge images (A3 and B3) show the preserved 
hippocampal slice integrity and organization. Confocal images were acquired with a 5x objective. Scale bars, 200 μm. 
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4.1.2 Cell death is not Serum-dependent    
To determine if serum removal plays a role in cell death of the explants, PI staining was 
analyzed. PI uptake was measured in each slice through the integrated density of 
fluorescence, normalized to the area and background fluorescence of each image in an 
independent way.  
As shown in Figure 13A, both conditions display PI-positive cells. Most of the PI-positive 
cells were concentrated in DG granule cell layer and CA3 and CA1 pyramidal cell layers, 
suggesting neuronal cell death. However, no differences were found comparing PI-
positive cells from slices growing in SC medium and SF medium. When comparing 
between hippocampal cell regions (CA1, CA3 and DG), CA1 region showed significantly 
higher PI uptake than DG in SC slices (152.9 ± 10.45 vs 104.4 ± 9.34, n=17, p<0.05), as 
well as in SF slices (152.2 ± 48.8 vs 105.6 ± 7.83, n=29, ***p<0.001). On the other hand, 
the CA3 region did not show a significant difference in cell death when compared to 
either CA1 or DG at either growth conditions (Figure 13B).  
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Figure 13| Propidium iodide (PI) uptake in OHSCs at 14 days in vitro (DIV). A) Representative PI staining 
indicating no differences between cell death in slices grown in serum-containing medium (SC) and serum-free 
medium (SF). B) Quantification of PI uptake by each hippocampal region expressed in arbitrary units of fluorescence 
intensity. Cell death is significantly higher in the CA1 cell region than it is in the dentate gyrus (DG). All values are 
mean ± SEM. 17 < slices < 29; p*<0.05, ***p<0.001, one-way ANOVA followed by Bonferroni’s Comparison Test. 
4.1.3 Serum-free Slices Develop Increased Spontaneous Epileptiform Activity 
The culturing of hippocampal slices provides the advantage of long-term use while 
retaining many aspects of the in vivo context (e.g. functional local synaptic circuitry and 
preservation of brain architecture). However, the mossy fiber pathway develops in vitro 
may be responsible for aberrant synaptic activity, causing organotypic slice cultures to 
be more excitable than acute slices. 
To investigate changes in OHSCs excitability caused by serum removal, field potential 
recordings from the CA3 region of slices at 14 DIV was performed. Field potential 
recordings showed spikes and short bursts of population activity, being particularly 
prominent in slices grown in SF medium (Figure 14). This suggests that serum-removal 
increased hyperexcitability of cells in these slices.    
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Figure 14| Representative field potential recordings of OHSCs at 14 days in vitro (DIV). A) Slice grown in serum-
containing (SC) medium shows single spikes with short amplitude. B) Slice grown in serum-free (SF) medium shows 
short bursts of population activity. All vertical bars = 1 mV (4 < slices < 6).  
4.1.4 Serum-removal Induces Alterations in Synaptic Excitability and Efficiency  
To further confirm the effects of serum removal on OHSCs functional properties, whole-
cell current clamp methods as well as extracellular field recordings were employed. 
Using the whole-cell patch clamp technique in current-clamp mode (section 3.3.2), the 
resting membrane potential of CA1 pyramidal cells was determined.  
Moreover, in order to assess synaptic transmission, an I/O plot (section 3.3.1.1) was 
constructed. Data was presented as the fEPSPs slope vs the stimulus intensity.  
4.1.4.1 Resting membrane potentials 
Whole-cell current clamp recordings were performed at 14 DIV from both conditions. 
The resting membrane potential of slices grown in SC medium  (-62.67 ± 1.26 mV, n=9) 
was significantly higher than the resting membrane potential measured in slices kept in 
SF medium (-55.57 ± 3.09, n=7) (Figure 15). These results indicate that the cell’s 
membrane potential of SF slices tend to become more positive. Since depolarized cells 
are more likely to fire an action potential, these results confirm the tendency of slices 
growing in a SF medium towards an increased synaptic excitability. 
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Figure 15| The resting membrane potential of CA1 pyramidal cells of OHSCs at 14 days in vitro (DIV), grown in 
serum-containing (SC) and serum-free medium (SF). 7 < cells < 9, *p<0.05, Unpaired t-Test. Experiments 
performed in collaboration with Diogo Rombo. 
4.1.4.2 Input-Output curves 
Synaptic field potentials were elicited by stimulation of CA1 pyramidal neurons using 
graded depolarizing stimulations, as described in section 3.3.1.1, in both growth 
conditions. As shown in Figure 16, the fEPSP response to stimulation of Schaffer 
collaterals in SC slices was four times higher than the one obtained from slices growing 
in a SF medium (maximum of 6.829 ± 1.172 mV vs 2.431 ± 1.105 mV, respectively). 
Nevertheless, the sensitivity to electrical stimulation was not affected, with the current 
required for half-maximal fEPSP amplitude being 180 µA, 1.212 ± 0.221 mV (n=4) in SF 
slices, and 3.657 ± 0.746 mV (n=4) in SC slices. These results indicated a reduced size 
of synaptic responses in SF slices, which can be traduced into a reduced synaptic 
efficiency of SF slices compared with SC slices. The correlation between fEPSP and the 
population spike (pSpike) was not possible to perform due to a huge contamination of 
the recordings with bursts of spikes stimuli-induced.  
 
M e m b r a n e  P o te n t ia l
S e r u m S e r u m -f r e e
-8 0
-7 0
-6 0
-5 0
-4 0
-3 0
C u ltu r e
In s e r ts
S l ic e s
n
1
1
2
9
1
2
3
7
*
M
e
m
b
ra
n
e
 P
o
te
n
ti
a
l 
(m
V
)
Results 
65 
 
Figure 16| Input-output curves obtained from OHSCs at 14 days in vitro (DIV) grown in serum-containing (SC) 
and serum-free medium (SF). The graph shows fEPSP amplitude (mean ± SEM) as a function of stimulus intensity 
(60-300 µA) in the CA1 stratum radiatum. The curves reflect the number of fibers activated at the different stimulus 
intensities and the fEPSPs that result from these activated fibers. Sensitivity to electrical stimulus intensity was similar 
between SC and SF growth medium condition, while response amplitudes, including the maximal response at 300 µA, 
were, on average, lower in SF growth medium condition. Curves fit to the data were significantly different by global 
analysis (**p<0.01, 4 slices, Unpaired t-test).  
4.2 In vitro Model of Epileptiform Activity  
OHSCs grown in serum-free medium spontaneously develop epileptiform discharges in 
the absence of pharmacological manipulation (section 1.2.1.1). Thus, in order to identify 
molecular and cellular hallmarks of epilepsy in OHSCs that are maintained in SF 
medium, as a model of epileptogenesis, epileptiform activity progression was firstly 
recorded and categorized from slices at 14 to 29 DIV. Then, immunofluorescence, 
western blot and mRNA expression assays were conducted using slices at two different 
times in culture – 14 DIV and 21 DIV.  
4.2.1 Interictal-like Spikes Precede Ictal-like Discharges  
To evaluate the progression of spontaneous epileptiform activity over the time in culture, 
field-potential recordings (30-40 minutes) were made from CA3 area after 14 to 29 days 
in culture under constant perfusion with 60 mL of recirculated growth medium at 37ºC.  
The recorded slices were grouped according to age and the spontaneous activity was 
classified as: (a) No population discharges, (b) Interictal-like discharges consisting of 
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single population spikes and, (c) Mixed Interictal- and Ictal-like discharges characterized 
by repetitive bursts of population spikes that last > 3 minutes including after discharges 
(Figure 17). Band-pass filtered (eight-pole Bessel filter at 60 Hz and Gaussian filter at 
600 Hz) field-potential recordings from 14 and 22 DIV OHSC reveals fast ripple-like 
complexes (data not shown).  
 
A – 14 DIV Interictal-like 
 
B – 21 DIV Ictal-like 
 
Figure 17| Representative spontaneous epileptiform activity recorded in organotypic slices. A – Interictal-like 
activity from a slice at 14 days in vitro (DIV); B – Mixed Interictal and Ictal-like discharges from a slice at 21 DIV. All 
vertical bars = 1 mV. 
 
As shown in Figure 18, at 14 to 17 DIV the majority (57.1%) of recorded slices (n=14) 
exhibited spontaneous interictal-like discharges, compared to mixed interictal- and ictal-
like discharges (35.7%). Inversely, slices at 21 to 29 DIV (n=22) displayed 
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predominantly mixed interictal- and ictal-like discharges (86.4%), compared to interictal-
like discharges alone (13.6%). Interestingly, ictal activity continued to rise with the 
number of days in vitro so that after 3 weeks in culture 90% of the recorded slices 
exhibited mostly ictal-like activity. 
 
Figure 18| Progression of spontaneous epileptiform activity over the time in culture. The graph shows the 
absolute percentage of slices developing: no population discharges, interictal-like discharges, and interictal- and ictal 
discharges. Slices obtained from 4 independent cultures.   
4.2.2 Astrocytes and Microglia are Activated   
Glial fibrillary acidic protein (GFAP) is a specific marker for differentiated astrocytes in 
the CNS. GFAP is the principal cytoskeletal protein in astrocytes and is thought to 
provide structural support for maintenance of cell shape. Therefore, reactive astrocytosis 
is defined by an increase in GFAP immunostaining plus an increase in the size and/or 
number of these cells 142. GFAP staining can result either from dissociation of glial 
filament bundles due to injury or due to increase in GFAP synthesis 143.   
Ionized calcium-binding adapter molecule 1 (Iba1), also known as allograft inflammatory 
factor 1 (AIF-1), is a microglia-specific calcium-binding protein. Microglia, considered as 
the tissue macrophages of the CNS, is present with a ramified morphology and low 
expression levels. Upon a pathological phenomenon, microglia are activated and adopt 
a reactive phenotype 144.  
Astrogliosis and microglia activation were evaluated by two distinct assays: western blot 
and immunohistochemistry.  
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4.2.2.1 Astrogliosis 
No significant differences (p=0.1718) in GFAP total expression were detected by 
western blot analysis (Figure 19) in 21 DIV slices with respect to the ones at 14 DIV.  
 
 
 
                 
Figure 19| Western blot analysis of GFAP and Iba1. A) Representative immunoblots of GFAP and Iba1. GAPDH 
was used as the loading control. B) Densitometry analysis performed with ImageJ software. All values are mean ± 
SEM. NS, not statistically significant (p>0.05), **p<0.01, N=6-8 slices, Unpaired t-Test. Statistical tests were 
performed in comparison with 14 days in vitro (DIV) slices. Experiments performed in collaboration with Daniela 
Magalhães. 
 
However, as observed in all hippocampal areas of 21 DIV slices, depicted in Figure 20 
B, the intensity of GFAP immunostaining was enhanced in comparison to the obtained 
in 14 DIV slices, showed in Figure 20 A. This suggests that a corresponding 
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enhancement in GFAP staining is due to the onset of injury and to the dissociation of the 
glial filament bundles to yield more epitopes available for binding to the GFAP antibody.    
 
Figure 20| Representative reactive astrocytosis in organotypic slices at 14 and 21 days in vitro (DIV). Detection 
of Hoechst stained nucleus (blue), together with NeuN (red) and GFAP (green), stained neurons and astrocytes, 
respectively. Confocal images were acquired with a 5x objective (A1 and B1) and 20x objective (A2-4 and B2-4). 
Scale bar, 200 µm. 
4.2.2.2 Microglia activation  
Inversely to GFAP, Iba1 overall expression was significantly higher (**p<0.01) in 21 DIV 
slices, Figure 19. These results were corroborated by the immunofluorescence images 
shown in Figure 21. Indeed, slices at 21 DIV, Figure 21 B, clearly show a strong 
enhancement in Iba1 immunoreactivity, in comparison with 14 DIV slices, Figure 21 A.  
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Figure 21| Representative microglia activation in organotypic slices at 14 and 21 days in vitro (DIV). Detection 
of Hoechst stained nucleus (blue), together with NeuN (red) and Iba1 (green), stained neurons and microglia, 
respectively. Confocal images were acquired with a 5x objective (A1 and B1) and 20x objective (A2-4 and B2-4). 
Scale bar, 200 µm. 
Furthermore, when comparing the amount of astrocytes and microglial cells, astrocytes 
are by far the most numerous, independently of the age of the explants, which was in 
accordance with has been already described 105. The age dependent increase in GFAP 
staining, as well as the upregulation of Iba1, might be related to the neurodegenerative 
process inherent to organotypic slices over the time in culture. It should however be 
noted that this investigation lacks measures of different explant times, in order to 
precisely look at the progression of astrogliosis and microglial activation.   
4.2.3 Inhibitory Neurotransmission Related Receptors are Altered  
The next section addresses the two main inhibitory neurotransmission systems in the 
CNS. Therefore, a transcript expression analysis of the ionotropic GABAA and glycine 
receptors was performed. Specifically, mRNA expression of GABAAR subunits (α1-5, 
β1-3 and γ2) and GlyR subunits (α1, α2, α3 and β) in the hippocampus of slices at 14- 
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and 21 DIV was evaluated by RT-qPCR with specific oligonucleotide primers, as 
detailed in Table 1 (section 3.4.1.3).  
4.2.3.1 GABAA receptor subunits 
Most GABAA receptor subunits transcripts were not altered in 21 DIV slices in respect to 
14 DIV slices. GABAA receptor α1 and β1 subunits mRNA levels exhibited a general 
trend to increase in 21 DIV (Figure 22), although no significance was exhibited (p=1.791 
and p=1.706, respectively). However, in 21 DIV slices, GABA receptor γ2 subunit 
showed a significant decrease (0.4400 ± 0.1877, p<0.05). 
 
 
 
Figure 22| Transcript expression profile of GABAA receptor (GABAAR) subunits α1-5, β1-3 and γ2. Composition 
analysis of GABAAR subunit mRNAs in slices at 14 and 21 days in vitro (DIV) by relative qPCR. All values are mean ± 
SEM. NS, not statistically significant (p>0.05), *p<0.05, N=4, Unpaired t-Test. Statistical tests were performed in 
comparison with 14 DIV slices. 
4.2.3.2 Glycine receptor subunits  
Regarding mRNA expression levels of GlyR subunits, α1 and β showed a significant 
increase (p<0.01), 2.975 ± 0.4050 and 1.553 ± 0.1215, respectively, from 14 to 21 DIV 
slices (Figure 23). Inversely, α3 subunit transcript profile revealed a significant decrease 
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(0.6633 ± 0.0273, p<0.001). Moreover, GlyR α2 subunit transcript level was not altered 
in 21 DIV slices (p=0.6757). 
 
 
Figure 23| Transcript expression profile of glycine receptor (GlyR) subunits α1-3 and β. Composition analysis of 
GlyR subunit mRNAs in slices at 14 and 21 days in vitro (DIV) by relative qPCR. All values are mean ± SEM. NS, not 
statistically significant (p>0.05), **p<0.01, ***p<0.001, N=4, Unpaired t-Test. Statistical tests were performed in 
comparison with 14 DIV slices. 
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5 DISCUSSION  
5.1 Organotypic Hippocampal Slice Cultures 
Rat hippocampal slice cultures grown by the interface membrane method were used in 
all experiments. This in vitro system gives a number of advantages over animal models 
by allowing easy access and precise control of extracellular environment, which makes it 
suitable to study detailed molecular mechanisms associated with epileptogenesis. To 
this end, however, it is needed the use of chemically defined culture medium in order to 
be able to control the cellular environment and avoid variations caused by various 
batches of serum.  
In this study, a method of changing progressively the medium from serum-containing 
(SC) to serum-free (SF) medium was developed. Compared with the conventional 
organotypic slices grown in SC culture medium, this SF method proved that the slices 
are kept structurally healthy, without differences in terms of cell death. 
Both conditions show preferentially cell lost in CA1 and CA3 areas of the hippocampus, 
whereas DG cells are more resistant. This pattern of cell loss is remarkably similar to 
what has been observed in resected human tissue MTLE and animal models of epilepsy 
8,145. The selective vulnerability in MTLE is associated with hyperexcitability of CA1 
neurons and has been proposed to result from sprouting of recurrent CA1 axon 
collaterals 146.  
Organotypic hippocampal slices are functionally connected uni-directionally. The EC 
projects to the DG via the perforant pathway. The DG then projects to the CA3 
pyramidal region via the mossy fiber pathway. The CA3 region projects to the CA1 
pyramidal region through the Schaffer collaterals. Finally, the CA1 region projects to the 
subiculum, which in turn, projects back to the EC completing the loop within the 
hippocampal formation. However, as a consequence of tissue slicing, axonal sprouting 
and reorganization of excitatory synaptic circuitry occurs during the time in culture 106. 
Newly sprouted axons may form synaptic contacts with intrinsically hyperexcitable cells, 
favoring the occurrence of epileptiform activity. Indeed, suppression of mossy fiber 
sprouting and reduction of ictal activity decreased cell death in OHSCs 113.  In order to 
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confirm this hypothesis, spontaneous activity in CA3 pyramidal cells, derived from both 
growth conditions, was recorded. Both slice cultures developed spikes of epileptiform 
activity, though this activity was particularly higher in amplitude and frequency in serum-
free slices.  Probably, SF slices have an increased connectivity of the hippocampal 
network, which increased synchrony and faster propagation of epileptic discharges 
within the hippocampus. 
To address the unanswered issue if serum withdrawal affects the momentary 
polarization level of the cell membrane and consequently the excitability of the cells, 
resting membrane potentials were measured. The cells’ membrane potential of SF slices 
showed a tendency to become more positive, and thus more likely to fire an action 
potential. On the other hand, when a neuron discharges from a more depolarized 
membrane potential, the action potential is proportionally smaller. Such amplitude 
reduction was posteriorly confirmed by extracellular recordings. SF slices showed for the 
same stimulus intensity a huge reduction in size of the post-synaptic response 
compared with slices grown in SC medium.  
Different categories of dendritic spines participate differentially in synaptic function. 
Dendritic spines provide an anatomic substrate for synaptic transmission, so that they 
also serve to increase the number of possible contacts between neurons. Abnormalities 
in dendrites, with a significant decrease in dendritic spine density, are frequently seen in 
hippocampal pyramidal neurons and dentate granule cells in patients with TLE 147. 
These evidences strongly suggest that alterations in dendritic spine structures or 
function could affect the processing of synaptic inputs and ultimately the excitability of 
neurons. In OHSCs, serum-withdrawal was reported to cause an increase in the fraction 
of “immature” thin spines while decreasing the proportion of “mature” stubby spines 
subtype 100. Additionally, granule layer cell density decreases over time in SF slices 
compared with cultures grown under SC medium 102. A loss of dendritic spines in 
organotypic cultures could lead to decreased excitability at the cellular level. However, if 
loss of excitatory input ultimately had a large effect on inhibitory networks, the net effect 
on circuit output might be increased excitability and a tendency toward seizures 147.  This 
suggests that the growth factors of serum could be an important variable for determining 
spine density of the explants. The change in size of synaptic responses observed can 
Discussion 
75 
reflect the lower synapse density in slices growing in SF medium. Nonetheless, this 
hypothesis was not evaluated in this work.  
Not only synaptic growth but also modifications of functional synaptic properties can be 
followed in OHSCs, which can explain why SF slices are more prone to develop 
spontaneous epileptiform activity. On the other hand, given the contribution of astrocytes 
on cytokine pathways and neurochemical interactions with neighboring neurons, it will 
be important to consider and evaluate the effect of serum in these glial cells and the role 
of these cells on neuronal synaptic functionality of the organotypic cultures.  
The functional measures used in this work were probably affected by various 
parameters, including the efficacy of neurotransmitter release, the postsynaptic 
sensitivity to the released neurotransmitter and the effects of inhibitory synaptic 
transmission. However, the magnitude of the observed changes and the close 
correlation found between changes in synaptic response size and the changes in resting 
membrane potential, as well as changes in synaptic density reported in previous works, 
highly suggest that these measurements were adequate to address the effects of serum 
on OHSCs.  
The present study indicates that OHSCs can be considered a model of epileptogenesis. 
Following the trauma of the culturing procedure, sprouting of mossy fibers within CA1 
area increase connectivity of the epileptic hippocampal network. The reorganization 
process of mossy fiber projection of the DG promotes a pattern of cell death, in which 
CA1 and CA3 are more vulnerable and DG is less affected. Moreover, it increases 
synchrony and faster propagation of epileptic discharges within the hippocampal 
structure. This intrinsic mechanism of increased excitability in organotypic cultures 
appears to be independent of the culture method, so that the use of SC or SF medium 
does not change these characteristics. The serum-withdrawal from the slice cultures 
affect dendritic spine morphology and possibly its function, since it was found that serum 
removal promote dendritic spine changes 100 and, according with the results of this work, 
reduces synaptic transmission efficiency. Serum starvation seems to play a significant 
role underlying persistent cellular hyperexcitability in the circuitry of the hippocampal 
formation. Nevertheless, future experiments should be performed in order to compare 
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the properties of synaptic transmission, as well as synaptic density of slices grown in the 
presence and absence of serum. 
It is also important to point out that evoked EPSPs in organotypic slices were quite 
difficult to obtain, essentially because high frequency stimulation triggers seizures, which 
abolished synaptic responses and makes analyses of synaptic potentiation quite 
unreliable. Still, the possibility of functional studies in cultured slices is an important step 
to validate the use of organotypic culture models.  
5.2 OHSC as a Model of Epileptogenesis 
As it was described above, OHSCs growing in a chemically defined growth medium, SF, 
spontaneously develop epileptiform activity. Moreover, it was described that the 
epileptiform activity develop later than 7 DIV, with primarily interictal-like spikes and 
burst at 14 to 17 DIV and preceding increasingly ictal-like spikes discharges after 21 DIV 
111. This in vitro system bears many similarities to in vivo epilepsy, including the 
appearance of spikes before seizures, the progressive increase in seizure-incidence, 
and the mix of interictal and ictal activity. Early acute cell death occurs as a result of 
brain slicing, and after 7-10 DIV a second peak of cell death takes place, overlapping 
the peak of seizure-like activity. Furthermore, suppression of ictal and interictal activity 
and ictal cell death did not prevent epileptogenesis 112. However, in order to establish a 
relationship between spontaneous seizures, neuronal death and epileptogenesis, many 
questions have to be firstly addressed regarding epileptogenesis hallmarks underlined 
by this in vitro model. For example, it is unknown the role of glial cells and the inhibitory 
synaptic transmission alterations in the induction and maintenance of seizure activity in 
this model.  
In this work, organotypic hippocampal cultures, progressively depleted of serum in the 
growth medium, were used as a model of post-traumatic epileptogenesis to monitor the 
events following brain explant, and to characterize the epileptic correlates concerning 
astrogliosis and microglia activation, as well as GABAA and Glycine receptor transcripts 
expression. Extracellular slice recordings from CA3 region, while bathed in growth 
medium, were consistent with previous reports in demonstrating predominance of 
interictal-like spikes and short bursts of population activity between 14 and 17 DIV, 
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which preceded the increasingly ictal-like discharges after 21 DIV. This result 
corroborates the development of spontaneous epileptiform activity in this in vitro model.  
One striking hallmark of the sclerotic hippocampus in MTLE is that while there is a 
specific pattern of neuronal loss, there is also reactive gliosis with hypertrophic glial cells 
exhibiting prominent GFAP staining and long, thick processes 26. Moreover, endogenous 
glial cells react to the lesion of cultured slice in a manner comparable to their reaction to 
lesions in vivo 148. Thus, in order to identify epileptic correlates in this in vitro model, 
GFAP- and Iba1-expression was analyzed in 14 and 21 DIV slices using two distinct 
assays: western blot and immunofluorescence staining. The expression of GFAP was 
detected in both groups of slices. Although increased GFAP expression was noticed by 
immunofluorescence assays, no detectable increase in GFAP content was found by 
western blot. This result suggests that astrocytes proliferation and hypertrophy occur 
early following injury, and the gradual processes of accumulation of glial intermediate 
filaments and the formation of glia scars take place around 21 DIV. Probably, chronic 
astroglial activation resulting from early interictal-like activity increases inflammatory 
cytokine production, potentiates excessive synaptic activity, and induces activated 
astrocytes to migrate to the epileptic focus, resulting in sclerosis.  
Consistent with this hypothesis, Iba1 detection revealed a significant increase in slices 
at 21 DIV. Since Iba1 expression is upregulated upon microglia activation allowing the 
discrimination between surveying and activated microglia, this result indicates the 
presence of reactive microglia cells at this stage of culture. However, to confirm this 
hypothesis a most detailed research regarding microglia morphology has to be 
performed. Taken together, these results strongly suggest that glial cells are altered, 
which may explain why preventing epileptiform activity, cell death and mossy fiber 
sprouting is not sufficient to prevent epileptogenesis in this in vitro model.  
 
It has been highly postulated that dysfunction of the GABAergic transmission is related 
to the development of epilepsy, since several animal models of TLE and human studies 
have revealed considerable changes in the expression of GABAA receptor subunits in 
the hippocampus 47,51. On the other hand, recent evidences suggest that glycine 
receptors are functionally expressed in adult hippocampal neurons, mediating mostly 
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tonic currents 60,72,149, and playing a role in epilepsy 80,81. Moreover, molecular 
interaction were described to occur between GABAA and glycine receptors, which 
provide cross-inhibition in the hippocampus 150. This interaction may have physiological 
implications in maintaining the balance between inhibitory and excitatory 
neurotransmission.  
In this work, the levels of GABAA and glycine receptors subunits were evaluated in this 
in vitro model of epileptogenesis. No significant changes between 14 and 21 DIV slices 
were found in GABAAR α and β subunits, but γ2 subunit decreased at 21 DIV. However, 
a spatial characterization of the GABAAR subunits is needed, since the expression 
pattern of the GABAAR subunits varies regionally and is highly cell type specific, which 
may be altered by external stimuli 151. For example, significant decreases in α1-, α3-, β3-
, and γ2-subunits were found in the CA1 area of sclerotic hippocampal specimens 
obtained from surgery of TLE patients, whereas pronounced increases of all three β-
subunits were observed in most areas of the hippocampal formation, being especially 
pronounced in the dentate molecular layer and the subiculum where subunit α3- and γ2- 
were also elevated 51. Likewise, changes in subunit composition in this in vitro model 
may occur differently according to hippocampal areas. Nevertheless, the general 
decrease of γ2-subunit mRNA level may be somehow related with a decrease of 
synaptic GABAARs, since γ2 subunit integrates synaptic receptors 152.  
Regarding GlyR subunits, α1 and β showed a significant increase at 21 DIV in 
opposition to α3-subunit, which revealed a significant decline from 14 to 21 DIV slices. 
Given that in mature hippocampal neurons synaptic GlyR were found to contain α1 
subunit 72, these results might indicate an increase of synaptic GlyR α1β in detriment of 
extrasynaptic GlyRα3. However, further experimental support from immunofluorescence 
assays is needed.  
 
Although the functional meaning of these results is difficult to comprehend since they 
lack of a more detailed characterization, the expression pattern changes of subunits may 
reflect seizure-induced rearrangement of GABAA and glycine receptors in some 
subfields of the hippocampal formation. Indeed, it is known that neuronal activity is able 
to regulate the regional expression in vitro 151.  Alternatively, these changes may be 
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caused by neurodegeneration. Altered subunit composition or modulation in chronically 
epileptic tissue could conceivably lead to altered pharmacosensitivty of target channels 
or receptors 11.  
Thus, a better knowledge about cellular expression and rearrangement of the inhibitory 
transmission related receptors during epileptogenesis and during the chronic phase of 
epilepsy might lead to the development of adequate treatments, and also to the 
understanding of the pharmacoresistance of AEDs that act upon the GABAergic system. 
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6 CONCLUSIONS  
This study demonstrates that a simple methodological approach, by withdrawing 
progressively serum from the culture medium, enables cultured hippocampal slices to 
grow without a permanent support of neurotrophic factors. These slices retain intact 
synaptic networks, as manifested by a demonstration of evoked excitatory post-synaptic 
potentials (EPSP) upon stimulation of Schaffer collaterals.  
It is important to note, however, that there are also some properties of cultures grown 
within a progressive serum-free medium that differ from cultures grown in a serum-
based medium. In both culture methods, it was found substantial evidence that 
spontaneous recurrent epileptiform activity, as well as a pattern of neuronal death 
occurs as a result of the initial trauma of tissue slicing. However, serum-withdrawal 
induces functional alterations on organotypic hippocampal cells, which seems to greatly 
increase the vulnerability and incidence of spontaneous epileptogenesis. 
Looking in more detail to the development of cultured slices growing in a serum-free 
medium, it is ascertainable the reproduction of many features of the severe post-
traumatic epilepsy, including the progress of epileptiform activity from a pattern of 
interictal-like activity at early stages to ictal-like activity at late stages of the slice in 
culture. Moreover, the ongoing reactive gliosis overlaps with the progression pattern of 
epileptiform activity.  
Hence, together with the continual emergence of studies successfully translating results 
from in vitro to in vivo, this in vitro model of OHSCs can be considered highly suitable to 
study epileptogenesis and also to screen potential anticonvulsant and antiepileptogenic 
drugs.  
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8 APPENDIX  
8.1 qPCR standard and melting curve analysis 
For the analysis of the transcript expression, 5-fold serial dilutions of the cDNA net 
solutions were used to create a standard curve for each gene. As explained in section 
3.4.1, the Pfaffl relative quantification method requires the crossing point (CP) 
determination indicated by the threshold (red line) in the normalized fluorescence vs 
cycle plot (panels A in each figure). The standard curves were created by ploting CP vs 
the log concentration of cDNA (ng/uL) (panels B). The parameters calculated using the 
standard curve are efficiency (E), relative expression rate (R) and slope value (M). Slope 
value is required in order to calculate the amplification efficiency [E=10^(-1/slope)] for 
the Pfaffl relative quantification method and should be included in the [3.1; 3.7] interval. 
E(Corbett) is a parameter determined by the software which is a measure of the overall 
efficiency of the reaction and should be included in the [0.85; 1.10] interval. R2 gives a 
measure of the fitting of the linear regression and the linearity of the PCR assay. The 
assessment of the reaction specificity was also evaluated by melting curve analysis 
(panels C). The visualization of one single peak in the Derivate (dF/dt) vs Temperature 
plot indicates a specific amplification of the targeted gene. All plots were created using 
Corbett software (Corbett Life Science). The following figures illustrate qPCR standards 
and melting curves analysis for each analyzes gene.  
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Figure 24| qPCR Standard and melting curves analysis for the GAPDH gene - endogenous control. (A) PCR 
amplification plot for the GAPDH gene. (B) Parameters calculated using standard curve created by plotting CP vs. the 
log concentration of cDNA (ng/uL). (C) Assessment of the reaction specificity by melting curve analysis. 
 
 
Figure 25| qPCR Standard and melting curves analysis for the GABAARα1. (A) PCR amplification plot for the 
GABAARα1 gene. (B) Parameters calculated using standard curve created by plotting CP vs. the log concentration of 
cDNA (ng/uL). (C) Assessment of the reaction specificity by melting curve analysis. 
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Figure 26| qPCR Standard and melting curves analysis for the GABAARα2. (A) PCR amplification plot for the 
GABAARα2 gene. (B) Parameters calculated using standard curve created by plotting CP vs. the log concentration of 
cDNA (ng/uL). (C) Assessment of the reaction specificity by melting curve analysis. 
 
 
Figure 27| qPCR Standard and melting curves analysis for the GABAARα3. (A) PCR amplification plot for the 
GABAARα3 gene. (B) Parameters calculated using standard curve created by plotting CP vs. the log concentration of 
cDNA (ng/uL). (C) Assessment of the reaction specificity by melting curve analysis. 
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Figure 28| qPCR Standard and melting curves analysis for the GABAARα4. (A) PCR amplification plot for the 
GABAARα4 gene. (B) Parameters calculated using standard curve created by plotting CP vs. the log concentration of 
cDNA (ng/uL). (C) Assessment of the reaction specificity by melting curve analysis. 
 
 
Figure 29| qPCR Standard and melting curves analysis for the GABAARα5. (A) PCR amplification plot for the 
GABAARα5 gene. (B) Parameters calculated using standard curve created by plotting CP vs. the log concentration of 
cDNA (ng/uL). (C) Assessment of the reaction specificity by melting curve analysis. 
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Figure 30| qPCR Standard and melting curves analysis for the GABAARβ1. (A) PCR amplification plot for the 
GABAARβ1 gene. (B) Parameters calculated using standard curve created by plotting CP vs. the log concentration of 
cDNA (ng/uL). (C) Assessment of the reaction specificity by melting curve analysis. 
 
 
Figure 31| qPCR Standard and melting curves analysis for the GABAARβ2. (A) PCR amplification plot for the 
GABAARβ2 gene. (B) Parameters calculated using standard curve created by plotting CP vs. the log concentration of 
cDNA (ng/uL). (C) Assessment of the reaction specificity by melting curve analysis. 
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Figure 32| qPCR Standard and melting curves analysis for the GABAARβ3. (A) PCR amplification plot for the 
GABAARβ3 gene. (B) Parameters calculated using standard curve created by plotting CP vs. the log concentration of 
cDNA (ng/uL). (C) Assessment of the reaction specificity by melting curve analysis. 
 
 
Figure 33| qPCR Standard and melting curves analysis for the GABAARγ2. (A) PCR amplification plot for the 
GABAARγ2 gene. (B) Parameters calculated using standard curve created by plotting CP vs. the log concentration of 
cDNA (ng/uL). (C) Assessment of the reaction specificity by melting curve analysis.  
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Figure 34| qPCR Standard and melting curves analysis for the GlyRα1. (A) PCR amplification plot for the GlyRα1 
gene. (B) Parameters calculated using standard curve created by plotting CP vs. the log concentration of cDNA 
(ng/uL). (C) Assessment of the reaction specificity by melting curve analysis. 
 
 
Figure 35| qPCR Standard and melting curves analysis for the GlyRα2. (A) PCR amplification plot for the GlyRα2 
gene. (B) Parameters calculated using standard curve created by plotting CP vs. the log concentration of cDNA 
(ng/uL). (C) Assessment of the reaction specificity by melting curve analysis. 
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Figure 36| qPCR Standard and melting curves analysis for the GlyRα3. (A) PCR amplification plot for the GlyRα3 
gene. (B) Parameters calculated using standard curve created by plotting CP vs. the log concentration of cDNA 
(ng/uL). (C) Assessment of the reaction specificity by melting curve analysis. 
 
 
Figure 37| qPCR Standard and melting curves analysis for the GlyRβ. (A) PCR amplification plot for the GlyRβ 
gene. (B) Parameters calculated using standard curve created by plotting CP vs. the log concentration of cDNA 
(ng/uL). (C) Assessment of the reaction specificity by melting curve analysis. 
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